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1 Introduction 
1.1 Inflammatory bowel disease (IBD) 
Inflammatory bowel disease (IBD), which include 
Crohn’s disease (CD) and ulcerative colitis (UC), are 
chronic inflammatory disorders of the gastrointestinal 
tract. They are characterized by alternating phases of 
relapse and remission. Crohn’s disease patients present 
with fatigue, prolonged diarrhea (with or without 
bleeding), abdominal pain, fever and weight loss. CD may 
affect any part of the gastrointestinal tract and is 
pathologically defined as focal, transmural inflammation 
that may include stricturing (gut luminal narrowing), 
penetration (bowel perforation, fistula and abscess) and 
perianal disease (Lichtenstein, Hanauer, Sandborn, & 
Practice Parameters Committee of American College of, 
2009; Satsangi, Silverberg, Vermeire, & Colombel, 2006; 
Wallace, Zheng, Kanazawa, & Shih, 2014). In 
comparison, UC predominantly involves the colon and the 
rectum and it is characterized by diffuse, continuous and 
symmetric inflammation, restricted to the colonic mucosa. 
Patients often present with rectal bleeding, frequent stools, 
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mucus discharge, tenesmus and lower abdominal pain 
(Kornbluth & Sachar, 1997; Satsangi et al., 2006; Wallace 
et al., 2014). Additionally, patients with IBD have 
increased risk for developing intestinal dysplasia, 
adenocarcinoma of the colon and extraintestinal disorders, 
such as psoriasis or primary sclerosing cholangitis (PSC) 
(Bernstein, Wajda, & Blanchard, 2005; Huang, Chandra, 
& Shih, 2012). About 0.3% of the European population 
(2.5-3 million people) suffers from IBD and there is a 
constantly increasing prevalence and incidence worldwide 
(Burisch, Jess, Martinato, Lakatos, & EpiCom, 2013). The 
highest incidence rates are observed in Scandinavia, 
whereas the lowest rates are in Southern, Eastern Europe, 
suggesting a north-west/south-east gradient. UC is more 
common than CD, however both diseases cause a high 
degree of distress for the patients, as a result of early onset, 
fluctuating course, serious complications, reduced quality 
of life and lack of cure. The etiology of IBD is still not 
clear. It is thought to be combination of genetics, 
microbiome, immune system and environment, which lead 
to abnormal immune response against the microflora in 
genetically susceptible individuals (Wallace et al., 2014). 
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Epidemiological data reports that many environmental 
factors, such as antibiotic use, microbial exposure (both 
early and late in life) and possibly diet, contribute to the 
development of the disease (Bager, Simonsen, Nielsen, & 
Frisch, 2012; De Filippo et al., 2010; Hviid, Svanstrom, & 
Frisch, 2011). Moreover, there are complex genetic factors 
behind IBD, which indicate the dysregulation of genes, 
associated with innate and adaptive immunity e.g. IL-
23/Th17 pathway, TGF-β-pathway, TNF-pathway, NF-
κB-activation and T-cell activation (Ek, D'Amato, & 
Halfvarson, 2014; Wallace et al., 2014). These genes 
resemble a small part of a bigger picture, if we are to 
understand the polymorphism of IBD. In our study, we 
investigated the role of the microbiome and its interaction 
with the innate immune system, hoping to contribute to the 
understanding of the pathogenic mechanisms underlying 
IBD.        
1.2 Microbiota, E. coli mpk2 and B. vulgatus mpk 
The intestinal microbiota is a complex ecosystem, 
which resides on the 300-400m2 gut luminal surface, in 
close contact with mucosal epithelial cells and the immune 
system (Wallace et al., 2014). It is comprised of bacteria, 
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archaea, protozoa, anaerobic fungi, and different 
bacteriophages and viruses, with an estimated 1000+ 
species of microbes in total (Turnbaugh et al., 2007). 
Genomics experiments have shown that 98% of all 
detected genes belong to bacteria and the three most 
abundant genera were Bacteroides, Prevotella and 
Ruminococcus, (Arumugam et al., 2011). The microbiome 
composition between individuals is variable and may 
change over time due to extrinsic factors, e.g. exposure to 
specific types of food and medications (e.g. antibiotics) or 
intrinsic factors, such as the adaptive immune system 
(Caporaso et al., 2011). Other genera, which have 
consistently been detected, include Actinobacteria, 
Proteobacteria, Fusobacteria, Faecalibacteria and 
Bifidobacteria. The intestinal microbiota has a 
considerable effect on the health and well-being of the 
human organism. It has metabolic functions (e.g. 
fermentation and absorption of carbohydrates), trophic 
effects on gut epithelial cells and plays a pivotal role in the 
suppression of pathologic microbial growth as well as in 
the development and improvement of the immune system 
(Dore & Corthier, 2010).  
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Individuals with IBD have been shown to have 
changes in the composition of their microbiome, compared 
to healthy individuals (Frank et al., 2007; Ott et al., 2004).  
Many studies report a decrease in members of the genera 
Bacteroides and increase of Escherichia coli (E. coli) in 
patients with ulcerative colitis (Chassaing & Darfeuille-
Michaud, 2011; Lepage et al., 2011; Sokol, Lepage, 
Seksik, Dore, & Marteau, 2006; Wallace et al., 2014). 
Furthermore, in previous research, the commensal bacteria 
Bacteroides vulgatus mpk and E. coli mpk2 were 
investigated as to their capability to induce colitis in 
gnotobiotic IL-2-/- mice, which are a well-established 
model for microflora-triggered, chronic colitis in hosts 
(Autenrieth, Bucheler, Bohn, Heinze, & Horak, 1997; 
Sadlack et al., 1993). Germ-free and B. vulgatus mpk 
mono-colonized mice remain healthy, whereas E. coli 
mpk2 mono-colonized animals developed the disease. 
Moreover, a co-colonization with E. coli mpk2 and B. 
vulgatus mpk did not lead to colitis, suggesting, that B. 
vulgatus mpk has protective properties, which remain to 
be further elucidated.  
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In this study we investigate the maturation process 
of dendritic cells upon stimulation with colitogenic and 
non-colitogenic commensal bacteria and their effect on 
intestinal inflammation and IBD. For this purpose, we 
used the commensal E. coli mpk2 strain, which induces 
colitis, and the commensal B. vulgatus mpk strain, which 
prevents E. coli mpk2 induced colitis in IL-2–/– mice. 
1.3 Dendritic cells and their role in IBD. 
As the gastrointestinal tract represents one of the 
main entrances for pathogenic invasion, it has to be tightly 
controlled by the host immune system. Therefore, about 
80% of all leukocytes in human body reside in the gut 
associated lymphatic tissue (GALT), interacting with each 
other in a very complex manner, which is still not fully 
understood. An effective immune response to infectious 
agents or inflammatory products demands perfectly 
coordinated teamwork between the innate and adaptive 
immune system. Dendritic cells (DCs) are antigen 
presenting cells (APCs), which bridge the gap between 
innate and adaptive immunity. In comparison to other 
mononuclear phagocytes (MPs) such as monocytes and 
macrophages, DCs are distinguishable by their unique 
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morphology and ability to capture and process antigens, 
which are subsequently presented to naïve T-cells (Rutella 
& Locatelli, 2011). Dendritic cells, located in the 
intestines, are in close proximity to the luminal surface 
(Rescigno et al., 2001) and exert a strict control over the 
antigen traffic in the gut. They play a dual role in inducing 
an adaptive immune response against potentially harmful 
antigens, on one hand, and maintaining T-cell tolerance to 
self-antigens and commensal microbiota on the other 
(Steinman & Banchereau, 2007). Upon confrontation with 
pathogens and activation, DCs undergo maturation, which 
can be seen as a preparation for an effective 
communication with naïve T-cells. The maturation process 
is characterized by upregulation of major 
histocompatibility complex class II (MHC-II) and 
costimulatory molecules (e.g. CD40), as well as cytokine 
production and the ability to migrate and activate T-cells 
(Figure 1). Based on specific phenotypical appearance, as 
defined by the aforementioned features, three distinct 
maturation states were described: immature, semi-mature 
and fully mature DCs (Lutz & Schuler, 2002). 
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Figure 1: Illustrating phenotypical differences between 
DCs maturation states. 
The image is adopted and modified from (Lutz & Schuler, 2002). 
Immature DCs (green) are characterized by low expression of surface 
markers (MHC-II and CD40) and no pro-inflammatory cytokine 
secretion. They are able to induce T-cell anergy. Semi-mature DCs 
(blue) express more MHC-II and CD40, however lack of cytokine 
secretion. They are irresponsible to a second maturation stimulus and 
are proposed to induce Treg cells. Fully mature DCs (red) are 
distinguishable by the high amount of pro-inflammatory cytokines 
produced and their ability to induce T-cell mediated inflammation. 
Immature dendritic cells are resting APCs in peripheral 
tissues, such as the epidermis (Langerhans cells) or the 
lung epithelium, or the gastrointestinal mucosa. 
Functionally, they are characterized by continuous 
endocytosis, which does not lead to activation, maturation 
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or increased migration to lymph nodes. If stimulation does 
not take place they remain in a steady state in which they 
are sensing the environment, expressing small quantities 
of MHC-II and a basal level of costimulatory molecules 
(Lutz & Schuler, 2002; Mommaas et al., 1995). Without 
costimulatory molecules immature DCs cannot activate T-
cells, which leads to clonal T-cell anergy (Lutz & Schuler, 
2002; Schwartz, Mueller, Jenkins, & Quill, 1989). 
Immature DCs normally do not migrate, however 
spontaneous migration in the absence of stimulatory 
factors can occasionally occur (Lutz & Schuler, 2002; 
Randolph, 2001). In our experiment immature DCs are 
represented by unstimulated bone marrow-derived 
dendritic cells (BMDCs).  
The semi-mature state of DCs is defined as partial 
maturation with upregulation of both MHC-II and 
costimulatory molecules (e.g. CD40), but a lack of 
proinflammatory cytokine production such as TNFα, IL-
1β, IL-6 and IL-12b. In contrast with immature DCs, semi-
mature DCs demonstrate improved migration properties, 
which enables them to reach T-cells at their anatomical 
location (Lutz, 2012; Lutz & Schuler, 2002). The 
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induction of partially maturated DCs can be achieved in 
diverse ways (e.g. TNF- stimulation, LPS stimulation, 
bacterial stimulation)(Lutz & Schuler, 2002). In our 
experiment, we generate semi-mature DCs via stimulation 
with the symbiotic, non-colitogenic B. vulgatus mpk, 
which has been previously established by (Frick et al., 
2006) differing from the TNF induced semi-mature DCs, 
proposed by Lutz et al. (2002). The B. vulgatus mpk 
induced semi-mature DCs express intermediate levels of 
MHC-II and CD40 and low levels of proinflammatory 
cytokines. Furthermore, the semi-mature state was 
characterized by unresponsiveness to a second maturation 
stimulus (Frick et al., 2006; Perrot et al., 2007), indicating 
that semi-maturation is rather a distinct state and not an 
intermediary phase on the way to full maturation. 
Although the use of the term “semi-maturation” stays 
under debate, there is a high number of studies which have 
provided evidence for the existence of these cells and their 
tolerogenic potential (Braun et al., 2006; Frick, 
Grunebach, & Autenrieth, 2010; Lutz, 2012; Mills & 
McGuirk, 2004; Morel & Turner, 2011; Morelli et al., 
2005; Nouri-Shirazi & Thomson, 2006; Rutella, Danese, 
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& Leone, 2006; van Duivenvoorde, van Mierlo, Boonman, 
& Toes, 2006; Young, Merad, & Hart, 2007). Our 
proteomics experiment provides a detailed catalogue of 
differentially expressed proteins, aiming to characterize 
and distinguish the semi-mature state from the other two 
well-known maturation states.  
The potential of semi-mature DCs to induce 
peripheral tolerance depends on their ability to activate 
different types of regulatory T-cells (Belkaid & 
Oldenhove, 2008; Lutz, 2012). Regarding their origin, we 
differentiate between thymically-derived (natural) Treg 
cells and inducible Treg cells in the periphery. Regarding 
their phenotype, there are IL-10 producing T-regulatory 
cells (Tr1), TGFβ- producing T-helper cells (Th) and 
inducible Foxp3+ Treg (Belkaid & Oldenhove, 2008; Chen 
et al., 2003). The main function of Treg cells is to control 
peripheral homeostasis by limiting extensive immune 
response, initiated by effector T-cells. Under normal 
conditions, natural, thymically-derived Treg cells are 
sufficient to maintain peripheral homeostasis. However, 
the generation of additional, extrathymical Treg cells is 
required on certain occasions and in specific 
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environments, which are continuously exposed to 
microbes, e.g. the gastrointestinal tract. Under specific 
bacterial stimuli, dendritic cells develop the ability to 
induce new populations of antigen-specific Treg cells 
(Belkaid & Oldenhove, 2008) and thus play a key role in 
preserving intestinal integrity. Although the exact 
mechanism is incompletely understood, it has been 
proposed that DCs which secrete IL-10 lead to the 
development of IL-10+Tr1 cells, whereas TGFβ producing 
DCs induce Foxp3+ Treg cells (Lutz, 2012) (Figure 2). Our 
results may provide new ideas on the induction of Treg 
cells by dendritic cells, interacting with commensal 
bacteria, since we detect potential regulators of peripheral 
tolerance in semi-mature DCs. 
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Figure 2: Regulatory T-cells induction by semi-mature 
DCs 
The image is adopted and modified by Lutz et. al. 2012. Stimulation 
of immature DCs (green) leads to the development of two different 
semi-mature DCs. The IL-10 producing one on the left side induces 
IL-10+Tr1 cells and the TGFβ producing DC on the right induces 
Foxp3+ Treg cells. 
Fully mature DCs are mainly characterized by their 
potential to produce proinflammatory cytokines such as 
TNFα, IL-1β, IL-6 and IL-12b. Furthermore, they express 
high levels of MHC-II and costimulatory molecules and 
are crucial for the induction of T-cell immunity (Lutz, 
2012; Lutz & Schuler, 2002). Additionally, fully mature 
DCs are characterized by increased CCR7 expression and 
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the ability to migrate to secondary lymphatic organs such 
as regional lymph nodes or the spleen (Alvarez, Vollmann, 
& von Andrian, 2008; Johnson & Jackson, 2014; Saban, 
2014; Teijeira, Russo, & Halin, 2014).  Mechanistically, 
increased cytokine production is induced via signals, 
associated with pathogen recognition such as pathogen-
associated molecular patterns (PAMPs) and their detection 
by pattern-recognition receptors (PPRs) (Lutz & Schuler, 
2002). An example of such receptors are toll-like 
recognition receptors (TLRs), which were first discovered 
in Drosophila (Medzhitov, Preston-Hurlburt, & Janeway, 
1997) and were later found on the surface of antigen 
presenting cells such as DCs. APCs use TLRs as sensors, 
which are crucial for the innate immune system to decode 
the type of invading pathogen and initiate an appropriate 
immune response. There are 13 different TLR proteins, 
each specific for different PAMPS. For example, TLR2 
detects bacterial peptidoglycans, TLR3 – double stranded 
DNA, TLR4 – lipopolysaccharide (LPS), TLR5- bacterial 
flagella and TLR9 – viral DNA rich in unmethylated CpG 
motifs (Lu, Yeh, & Ohashi, 2008). One of the best studied 
interactions is the one between TLR4 and LPS, an 
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important structural component of the outer membrane of 
Gram-negative bacteria (in our study B. vulgatus mpk and 
E. coli mpk2). LPS stimulation involves many proteins, 
including LPS-binding protein (LBP), CD14, MD-2 and 
TLR4. CD14 facilitates the transfer of LPS to the 
TLR4/MD2 receptor complex and modulates LPS 
recognition (Lu et al., 2008). Subsequently, a series of 
intracellular cascades are induced, which can be divided 
into MyD88-dependent and MyD88-independent 
pathways. The first one leads to the production of multiple 
pro-inflammatory cytokines and the second one to Type 1 
Interferon secretion (Lu et al., 2008). 
Other mechanisms, involved in PAMPs recognition, 
include intracellular NOD-like receptors (NLRs) and 
activation of the inflammasome. Inflammasomes are the 
interface between TLRs and NLRs and resemble 
multiprotein complexes that are responsible for the 
activation of inflammatory caspases. Caspase 1, for 
example, is required for the cleaving of the biologically 
inactive IL-1β and thus controls its activation (Church, 
Cook, & McDermott, 2008). IL-1β is one of the most 
important cytokines during inflammation and is primarily 
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produced by cells of the monocytic linage (Dinarello, 
1996; Eder, 2009). It causes fever, hypotension and 
production of additional proinflammatory cytokines 
(Church et al., 2008). The release of IL-1β encompasses 
three steps: (i) transcription of the biologically inactive 
pro-IL-1β, (ii) cleavage of pro-IL-1β by caspase-1 and (iii) 
secretion of the biologically active, mature IL-1β into the 
extracellular milieu (Eder, 2009). Overproduction of IL-
1β can be detrimental for the surrounding tissue and has 
been reported to be associated with wide variety of 
diseases, including atherosclerosis, type 2 diabetes, 
neurodegenerative and autoimmune disorders, such as 
rheumatoid arthritis, multiple sclerosis and Crohn’s 
disease (Church et al., 2008).   
Although DC maturation is an extensively 
investigated topic in the literature, the underlying 
molecular patterns creating the difference between 
immature, semi-mature and fully mature DCs, are only 
marginally understood. The purpose of our experiment is 
to provide a more detailed picture of the maturation 
process of DCs, using proteomics as a tool.      
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1.4 Reactive oxygen species 
ROS are highly reactive, oxygen containing 
molecules, which include free radicals i.e. superoxide 
anion (·O2
-), hydroxyl radical (·OH), peroxyl radical 
(ROO·), alkoxyl radical (RO·) and thiol radical (RS·), as 
well as non-radicals such as hydrogen peroxide (H2O2) and 
singlet oxygen (1O2) (Oyinloye, Adenowo, & Kappo, 
2015).  
ROS can originate from external and internal 
sources.  We are constantly exposed to external sources, 
e.g. ionizing radiation, ultra violet (UV) light and general 
pollution, such as smoking, car exhaust fumes and factory 
fumes. Internal sources include, on the one hand, innate 
immune cells involved in killing invading pathogens in a 
process called “oxidative burst” and; on the other hand, the 
electron transport chain (ETC) in the mitochondria, which 
is crucial for the metabolism of all body cells. It is believed 
that around 1% of all passing electrons are leaking from 
the ETC and thereby reducing O2 to superoxide radicals, 
which are subsequently converted to hydrogen peroxide by 
the superoxide dismutase (SOD). In general, ROS are 
harmless at low concentrations and play an important role 
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as second messengers in many physiological processes and 
cell signaling cascades. However, under certain 
circumstances, such as pathogen confrontation, 
inflammation and injury, ROS production may rise to 
levels that overwhelm the antioxidant capacity of the cell. 
Prolonged exposure to oxidative stress causes damage to 
important structural components i.e. lipids, proteins, 
carbohydrates and deoxyribonucleic acid (DNA) (Alfadda 
& Sallam, 2012; Martinon, 2010; Pham-Huy, He, & 
Pham-Huy, 2008). For example, by reacting with 
polyunsaturated fatty acids of cell membranes, free 
radicals are able to initiate a vicious chain reaction, 
referred to as lipid peroxidation, which subsequently leads 
to membrane destruction (Del Rio, Stewart, & Pellegrini, 
2005; Pham-Huy et al., 2008). Proteins can also be 
damaged by the oxidation of amino acids, especially 
cysteine residues, leading to structural changes and 
enzymatic dysfunction (Halliwell, 2007). Furthermore, 
damage to DNA can be caused by ROS, inducing single 
oxidative lesions or strand brakes (Meira et al., 2008). If 
not properly repaired by DNA repair mechanisms, these 
changes can contribute to the development of deleterious 
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mutations and cancer. Oxidative stress has been linked to 
the pathogenesis of many chronic and degenerative 
diseases such as autoimmune disorders, arthritis, cancer, 
cardiovascular and neurodegenerative disease (Martinon, 
2010). There is a growing body of evidence, which show 
the important role of ROS in inflammatory bowel disease, 
however the exact mechanism and extent of involvement 
needs to be further studied.  
1.5 ROS and “leaky gut” syndrome 
Recently, ROS was associated with disruption of the 
intestinal epithelial barrier (Banan, Choudhary, Zhang, 
Fields, & Keshavarzian, 2000; A. Wang et al., 2014), 
which is characterized by increased epithelial 
permeability. As a result of altered intestinal permeability, 
bacteria and food antigens may enter the submucosa and 
induce severe inflammation. By invading the gut tissue, 
pathogens and inflammatory products gain access to the 
circulatory and lymphatic system, which can lead to 
disseminated spread to other organs, sepsis and death (A. 
Wang et al., 2014). This pathogenesis has been referred to 
as “leaky gut syndrome” and has been proposed as an 
additional hypothesis for explanation of autoimmune 
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diseases (Fasano, 2012). There is an increasing body of 
evidence demonstrating an association of gut epithelial 
barrier dysfunction with other somatic disorders, e.g. heart 
disorders, diabetes mellitus type I, cancer, IBD, asthma, 
multiple sclerosis, ankylosing spondylitis (Fasano, 2012; 
Rogler & Rosano, 2014; Saggioro, 2014), and mental 
disorders e.g. autism (Samsam, Ahangari, & Naser, 2014). 
We believe that the disruption of the intestinal mucosal 
barrier by ROS contributes to disease pathology in 
autoimmune diseases, especially in IBD.  
1.6 Antioxidants, Nrf2-pathway and Prohibitin 
(Phb1). 
To prevent excessive ROS production and tissue 
damage, living cells are equipped with defense 
mechanisms, classified as enzymatic antioxidants and non-
enzymatic antioxidants. The main enzymes that deal with 
radicals are superoxide dismutase (SOD), catalase (CAT), 
glutathione peroxidase (GPx) and glutathione reductase 
(GRx). SOD facilitates as a first line of defense in the 
mitochondria- SOD (Mn), or in the cytoplasm- SOD 
(Cu/Zn), the dismutation of two superoxide anions to 
oxygen and hydrogen peroxide. The H2O2 is neutralized to 
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oxygen and water either by catalase (CAT), or glutathione 
peroxidase (GPx). The latter removes hydrogen peroxide 
by using it to oxidize reduced glutathione (GSH) into 
oxidized glutathione (GSSG), which is then reduced back 
to GSH by the flavoprotein enzyme Glutathione reductase 
(Pham-Huy et al., 2008).  
Non-enzymatic antioxidants are divided into 
metabolic antioxidants, produced in the body, and nutrient 
antioxidants, absorbed from food and food supplements, 
such as vitamin E, vitamin C, carotenoids, trace metals 
(selenium, manganese, zinc), flavonoids, omega-3 and 
omega-6 fatty acids (Pham-Huy et al., 2008). The most 
important metabolic antioxidants include glutathione, L-
ariginine, coenzyme Q10, melatonin and metal-chelating 
proteins. In general, when an antioxidant destroys a free 
radical, this antioxidant itself becomes oxidized and must 
be either detoxified by another antioxidant, or it remains 
unreactive by delocalizing of its free electrons. The latter 
is characteristical for antioxidants, rich in conjugated 
double bounds, such as Vit. C, E, Coenzym Q10 etc.   
A key regulator in the endogenous antioxidant 
system is the nuclear factor erythroid 2-related factor 2 
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(Nrf2). This is a transcription factor, responsible for the 
activation of a great variety of cytoprotective genes, 
including antioxidant, detoxification and metabolic 
control enzymes (Hybertson & Gao, 2014). Under steady 
state, Nrf2 is repressed by the redox sensitive kelch-like 
ECH-associated protein 1 (Keap1). Upon reaction with 
ROS or other electrophiles, Keap1 releases Nrf2 allowing 
it to enter the nucleus, where it initiates the transcription 
of antioxidant response elements (AREs). Among other 
major representatives of AREs there are important 
antioxidant enzymes i.e. superoxide dismutase (Sod1 
Cu/Zn), glutathione s-transferase omega-1 (Gsto1), 
thioredoxin (Txn) and glutamate-cysteine ligase (Gcl) 
(Hayes & Dinkova-Kostova, 2014; Higgins et al., 2009; 
Theiss, Vijay-Kumar, et al., 2009). The aforementioned 
SOD is one of the integral enzymes for detoxifying 
peroxide anions to hydrogen peroxide in the mitochondria 
and cytoplasm of the cell. Gsto1 and Gclm are crucial 
proteins for intracellular glutathione homeostasis 
(McMahon et al., 2001). As mentioned before, glutathione 
is responsible for neutralizing the product of SOD - H2O2 
in the cell plasma and thus to completely restore the redox 
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balance in the cell (McMahon et al., 2001). Besides the 
GSH based antioxidant system, Nrf2 controls the 
expression of cytoplasmic thioredoxin, which is 
responsible for the reduction of oxidized protein thiols, 
common products of glutathione oxidation (Hawkes, 
Karlenius, & Tonissen, 2014; Hayes & Dinkova-Kostova, 
2014). Thus, Txn, together with Gsto1, Sod and Gclm 
represents a major member of the antioxidant capacity of 
the cell. 
The activation of Nrf2/Keap1 pathway is tightly 
controlled. Under normal homeostatic conditions, Nrf2 is 
kept at low levels by targeted proteosomal degradation by 
ubiquitination (Hayes & Dinkova-Kostova, 2014). The 
expression of the transcription factor is regulated on a 
genetic (gene polymorphism), transcriptional, 
translational and post-translational levels (Hayes & 
Dinkova-Kostova, 2014). Furthermore, there are regulator 
proteins such as Prohibitin (Phb1) and p62/sequestosome 
1 (p62/SQSTM1), which can influence the Nrf2/Keap1 
pathway by different mechanisms. P62/SQSTM1, for 
example, inhibits Keap1 by competing with Nrf2 for the 
binding site and thus positively regulating Nrf2 expression 
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(Copple et al., 2010; Hayes & Dinkova-Kostova, 2014; 
Komatsu et al., 2010). Prohibitin (Phb1) has also been 
shown to exert a positive regulation on the major 
antioxidant pathway, however the mechanism is not 
completely understood (Theiss, Vijay-Kumar, et al., 
2009). Phb1 is an ubiquitously expressed, highly 
conserved protein, which has multiple functions in the cell 
including regulation of proliferation and apoptosis, 
regulation of transcription, and mitochondrial protein 
folding (Theiss & Sitaraman, 2011).  Phb1 was 
demonstrated to be downregulated during oxidative stress 
in cultured intestinal epithelial cells, IBD and mice models 
of colitis (Theiss et al., 2007; Theiss, Vijay-Kumar, et al., 
2009). The same research group demonstrated a clear 
relationship between Prohibitin overexpression in the 
intestines and upregulation of glutathione during oxidative 
stress. Phb repletion was further shown to protect from 
oxidant-induced epithelial barrier dysfunction and colitis 
in mice models (Theiss, Vijay-Kumar, et al., 2009). Due 
to its beneficial regulatory properties, Prohibitin is now the 
target of new therapeutic approaches in IBD (Theiss & 
Sitaraman, 2011). 
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1.7 Aims 
Dendritic cell maturation is an extensively 
investigated topic, however, the underlying molecular 
patterns creating the differences between immature, semi-
mature and fully mature DCs are marginally understood. 
The aim of this doctoral thesis is to investigate the 
interaction of symbiotic and pathobiotic bacteria with 
dendritic cells and gaining more insight into the 
pathogenic mechanisms underlying IBD. By using 
proteomics as a tool, we intend to provide a more detailed 
picture of the maturation process of DCs by generating a 
comprehensive list of differentially regulated proteins 
between distinct DC maturation states. Moreover, we 
intend to provide functional clues by systematically 
clustering these proteins into biological processes and 
effectively visualizing them on Voronoi treemaps in 
multiple levels of detail. Relevant processes e.g. 
inflammation, migration and stress response will be 
further investigated to reveal regulatory proteins that may 
play a crucial role in creating the differences between 
semi-mature and fully mature DCs. Finally, we will 
explore in detail ROS generation in dendritic cells upon 
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bacterial challenge, in conjunction with the different 
antioxidant capacities of distinct DC maturation states, as 
demonstrated in our proteomics experiment.
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2 Materials and Methods 
2.1  Bacterial cultures 
2.1.1 Escherichia coli mpk2 
5ml of LB (Lysogeny Broth)-medium was 
inoculated with 50µl E. coli mpk2 stock solution and 
incubated overnight on a shaker at 37˚C. The next day, 
300µl of the overnight culture was used to inoculate 20ml 
of fresh LB-medium for 2.5 hours at 37˚C on a shaker. 
2.1.2 Bacteroides vulgatus mpk 
Four days before usage, 50µl from B. vulgatus mpk 
stock solution was used to inoculate 10ml liver-bouillon 
and was incubated under anaerobic conditions, at 37˚C for 
3 days. After incubation, 5ml of the three-days-old culture 
was used to inoculate 45ml BHI (Brain Heart Infusion)-
medium and the suspension was kept overnight under 
anaerobic conditions at 37˚C.  
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2.2 Cell culture 
2.2.1 Bone marrow derived murine dendritic cells 
(BMDCs) 
2.2.1.1 Cell culture medium for BMDCs 
The medium used for generating BMDCs out of 
primary bone marrow cells consists of 500ml VLE-RPMI-
medium (Biochrom), supplemented with 10% heat 
inactivated (57°, 30min) fetal calf serum (FCS, Sigma), 
1% non-essential amino acids (Biochrom), 100 Units/ml 
Penicillin (Invitrogen), 100µg/ml Streptomycin 
(Invitrogen), 50µmol/l 2-Mercaptoethanol (Sigma) and 
10% GM-CSF (Granulocyte macrophage colony-
stimulating factor), produced by the murine myeloma cell 
line P3X63 in house.  
2.2.1.2 Isolation and culturing of BMDCs 
Primary bone marrow cells were isolated from 
the femur and tibia of C57BL/6 mice and cultured 
according to a protocol established previously (Madaan, 
Verma, Singh, Jain, & Jaggi, 2014). Mice were killed by 
CO2 asphyxiation, followed by cervical dislocation.  
Femur and tibia were separated from the surrounded tissue 
    
                           
Materials and Methods 
 
29 
 
with sterile instruments. After removal, the bones were 
plated in sterile Phosphate Buffered Saline (PBS [+] 
MgCl2 [+] CaCl2 [+], GIBCO). In a class two biosafety 
cabinet, the bones were cleaned from muscular tissue and 
separated from the knee joint. Epiphysis were cut and the 
bone marrow was flushed with PBS out of the diaphysis 
on a cell filter (BD Falcon, 100μm), using a syringe 
(Braun). Cell suspension was subsequently spun down for 
5min at 400g, supernatant was taken out and cells were 
resuspended in 10ml BMDC medium. After counting with 
a hemocytometer, 2 x 106 cells were cultured in 10ml 
BMDC-medium in a 10cm petri dish (Falcon) and kept in 
a cell culture incubator. Medium was refreshed on days 3 
and 6 after bone marrow isolation. Generated dendritic 
cells are harvested after seven days of culture for 
experiments. All animal experimentations are done by 
qualified personal and confirm to the rules and guidelines 
of University Hospital Tübingen and the land of Baden-
Württemberg. 
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Figure 3: Culturing BMDCs 
Each step of an experimental setting for culturing immature dendritic 
cells out of extracted bone marrow progenitor cells. The image is 
adopted and modified from (Madaan et al., 2014). 
2.2.2 In vitro dendritic cell stimulation with bacteria 
On day 7 of DC culture, the cells were scraped out 
and replated on 6-12-well plates (Falcon, non-tissue 
treated) for stimulation, using 1ml medium per 1x106 cells. 
After 2 hours in the cell incubator, DCs were inoculated 
with B. vulgatus mpk and E. coli mpk2 with a MOI 
(Multiplicity of infection) of 1 and incubated further for 5 
min and 16 hours in the cell culture incubator. 1µg/ml of 
Gentamycin was added to the culture to prevent 
multiplication of the bacteria (Figure 4).  
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Figure 4: Stimulation of BMDCs 
Stimulation of cultured immature dendritic cells with B. vulgatus 
mpk (MOI 1) and E. coli mpk2 (MOI 1). Samples were collected 5 
minutes and 16 hours after stimulation and prepared for proteome 
analysis. 
2.2.3 Restimulation with E. coli mpk2 
After refreshing the medium, cells previously 
stimulated with B. vulgatus mpk and E. coli mpk2 as well 
as the unstimulated control cells, were restimulated with 
E. coli mpk2 (MOI 1) for another 16 hours (Figure 5). 
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Figure 5: Restimulation of BMDCs 
E. coli mpk2 restimulation of untreated, B. vulgatus mpk and E. coli 
mpk2 pretreated cultures. After 16h samples were collected and 
analyzed for maturation check with FACS and ELISA. 
2.2.4 Sample collection from stimulated BMDCs 
2.2.4.1 Protein sample collection for Proteome analysis 
Protein samples were collected 5 minutes and 16 
hours after stimulation for each of the three conditions: 
treated with E. coli mpk2, treated with B. vulgatus mpk 
and untreated. After incubation with bacteria, cells were 
scraped and washed with sterile PBS. After centrifugation, 
the pellet was resuspended in 0.5ml of lysis solution (6M 
urea, 2M thiourea in 50mM Tris pH 8.0, 1% N-
Octylglucoside + phosphatase inhibitors: 1mM Sodium 
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orthovanadate, 5mM Glycerol-2-phosphate, 5mM Sodium 
fluoride). After ten minutes incubation on ice, 0.5% 
benzonase was added to the suspension and kept for 12min 
at room temperature, in order to digest DNA. After 
incubation, samples were centrifuged at 2800g, 10˚C for 
22 minutes and the supernatant was frozen for subsequent 
proteome analysis. 
2.2.4.2 Protein sample collection for Western blot 
The protein samples for Western blot were 
collected similarly to those for proteome analysis: 5 
minutes and 16 hours after stimulation for all the three 
conditions. Cells were scraped and washed twice with 
PBS. Afterwards the cell pallet was resuspended in 100µl 
of lysis buffer (1% Triton-X-100, diluted in PBS + 
Protease inhibitor (1 Tablet in 2ml distillated water and 
mix 1:25 with the 1% Triton-X-100)). After rotation at 4˚C 
for 15min, cells were centrifuged at 8000rpm 4˚C and 
stored at -20˚C. 
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2.3 Detection of surface marker expression with 
FACS 
After 5 min and 16 hours of incubation, the cells 
were scraped out and centrifuged. Pellets were 
resuspended in 150µl Fc-Block and incubated (+4˚C, 
15min) in darkness. After washing with PBS + 1% FCS, 
150µl cell suspension was stained with 0.7µl monoclonal 
antibodies according to Table 2 below. Cells were 
incubated with the antibodies (+4˚C, 45min) in darkness 
and washed again with PBS + 1% FCS. Eventually, the 
pellet was resuspended in 150µl PBS + 1% FCS and 
transferred to FACS tubes (Greiner). 50µl of 4% PFA 
(Paraformaldehyde) was added for preservation. The 
samples were analyzed using BD LSRFortessa II cell 
analyzer (BD) for detecting the expression of cell surface 
activation markers CD40, MHC-II and CCR7 as well as 
the dendritic cell marker CD11c (see Table 1). The results 
from the flow cytometer were further analyzed using the 
Flow Jo software. 
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Table 1: Antibodies, used for FACS analysis. 
 
Monoclonal 
antibody  
Anti-mouse 
Clone  Isotype Catalog No./ 
Company 
CD 40 FITC HM40-
3 
Hamster IgM, 
κ 
553723, BD 
MHC-II FITC 2G9 Rat IgG2b, κ 553623, BD 
CD11c APC HL3 Hamster IgG1, 
λ2 
550261, BD 
CD11c FITC HL3 Hamster IgG1, 
λ2 
557400, BD 
CCR7 Biotin  4B12 Rat IgG2a, κ 13-1971-82, 
eBio  
Streptavidin 
APC 
  554067, BD 
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Table 2: Staining scheme with necessary controls. 
 
Samples Cells used 
1. Unstained 
2. MHC-II FITC single staining 
3. CD40 FITC single staining 
4. CD11c APC single staining 
5. CCR7 Bio + Strep. APC 
single staining 
 
Cell mixture 
6. CD11c APC, MHC-II FITC 
7. CD11c APC, CD40 FITC 
8. CD11c FITC, CCR7 Bio + 
Strep.APC 
 
Non-stimulated cells 
9. CD11c APC, MHC-II FITC 
10. CD11c APC, CD40 FITC 
11. CD11c FITC, CCR7 Bio + 
Strep.APC 
 
B. vulgatus  
stimulated cells 
12. CD11c APC, MHC-II FITC 
13. CD11c APC, CD40 FITC 
14. CD11c FITC, CCR7 Bio + 
Strep.APC 
 
E. coli stimulated cells 
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2.4 Measurement of cytokine secretion profiles from 
supernatants with ELISA 
At 16 hours after stimulation with B. vulgatus mpk, 
E. coli mpk2 and PBS for control, as well as the 
restimulated samples were centrifuged and supernatants 
were frozen for cytokines detection with ELISA. The 
following BD OptEIA-sets were used: TNFα (anti-mouse, 
catalog No: 554418, BD), IL-1β (anti-mouse, catalog No: 
559603) and IL-6 (anti-mouse, catalog No: 554401, BD). 
Maxi Sorb 96-well plates (Nunc) were coated overnight (4 
°C) with 100µl capture antibody (purified anti-mouse 
mAb). Afterwards, the plates were washed (2x) with 
ELISA-wash buffer and blocked, using 200µl Assay 
Diluent for 1 hour. Standards from the respective OptEIA-
sets were diluted accordingly, to obtain a standard curve 
and together with the probes, they were incubated in the 
already washed (1x) plate for 2 hours at room temperature. 
After 2 washing steps 100µl detection antibody 
(biotinylated anti-mouse mAb) + HRP (horse radish 
peroxidase)-streptavidine-enzyme, diluted 1:250 in Assay 
Diluent was added and the plate was incubated further for 
1 hour at room temperature. 100µl substrate solution was 
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added per well to the pre-washed plate (2x) and after 
20min incubation in darkness the reaction was stopped 
with 50µl sulfuric acid. The optical density (OD) of the 
probes was measured using the ELISA-reader and 
Magellan-V 6.6 as a software.  
Table 3: Materials and buffers 
 
Maxi Sorb 96-
well plates 
Nunc 
ELISA-Washer Tecan 
ELISA- wash 
buffer 
1 x PBS + 0,05 % Tween-20 
Coating buffer 
0,2 mol/l sodium phosphate - pH 6,5 
IL-6 - 0,1 mol/l 
sodium carbonate - pH 9,5 
Assay Diluent 1 x PBS + 10 % FCS 
Substrate 
solution 
tetramethylbenzidine + hydrogen 
peroxide 1:1 (TMD-reagents-set, BD) 
Stop-solution 50µl sulfuric acid 1 mol/l 
ELISA-reader Tecan SunRise 
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2.5 Western Blot for Prohibitin (PHB-1, anti-mouse) 
Protein collection for Western blot was described 
above (section 1.4.2). Protein concentration in samples 
was measured with Bradford-assay, which is based on the 
reaction of the Triphenylmethan Coomasie-Brilliant-Blau 
G-250 in an acidic milieu with the cationic, nonpolar side 
chains of a protein. Protein concentration was measured 
according to the photometrical results at the absorption 
maximum (595nm). BSA protein standards are used to 
obtain a standard curve. 30µg proteins per sample was 
loaded in a SDS-gel (see Table 4), dissolved in 15µl 
solution, consisting of 5x Laemmli-puffer, as a loading 
dye, and the rest – millipore water. 3µl molecular marker 
(PAGE Ruler Protein Ladder) was used as size standard to 
monitor the progress of the electrophoresis. The SDS-Page 
ran under 30mA and constant voltage for 2 hours. 
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Table 4: SDS-gel preparation 
 
10% separating gel 
 
Millipore water 
30% acrylamide mix 
1.5M Tris (pH 8,8) 
10% SDS 
10% APS 
              TEMED 
stacking gel 
 
Millipore water 
30% acrylamide mix 
1.0M Tris (pH 6,8) 
10% SDS 
10% APS 
TEMED 
 
After the SDS-Page run, a blot-sandwich in a wet blot 
puffer was prepared for transferring the proteins into a 
nitrocellulose membrane. The blotting ran at 300mA for 1 
hour. After run, the nitrocellulose membrane was 
incubated in LiCor Blocking Buffer (1h, at room 
temperature), than washed (3x10min) with Western Wash 
and eventually incubated with the primary antibody 
Prohibitin (Rabbit anti-PHB-1, cell signaling #2426), 
diluted in 5ml LiCor Blocking Buffer and 0.1% Tween 20 
and kept overnight, at 4˚C, under rotation. On the next day, 
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the membrane was washed (3x10min) and incubated with 
the secondary antibody (goat, anti-rabbit IRDye 680RD), 
diluted in 5ml LiCor Blocking Buffer, 0.2% Tween 20 and 
0.1% SDS and kept for 2h at room temperature, under 
rotation. The 700nm and 800nm fluorescence signal was 
measured with Li-Cor Odyssey. After obtaining results 
from the first staining, the membrane was stripped using 
strongly alkali stripping solution (10mM NaOH, 250 mM 
Guanidiniumchlorid) and stained again with β-Actin 
antibody (mouse, anti-β-Actin, catalog no. 4970, Cell 
signaling Technology) for loading control. The membrane 
was incubated for 1h with the primary antibody than 
washed (3x10min) and incubated for 45min with the 
secondary antibody (goat, anti-mouse IRDye 680RD). 
Fluorescence was measured once again by Li-Cor 
Odyssey. 
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Table 5: Buffers used for Western blot 
 
 5x Laemmli-buffer 2.5ml Tris  
(1M, pH 6.8) 
5ml Glycerin 
1g SDS 
0.5% Bromophenol 
blue 
Fill up to 10ml with 
aqua dest. 
 5x Electrophoresis buffer 50mM Tris 
384mM Glycine 
0.1% SDS 
Fill up to 1L with 
aqua dest. 
 10x Western blot buffer 25mM Tris, pH 8.3 
192mM Glycine 
0.02% SDS 
20% Methanol 
 Western wash buffer 500mL PBS 
               0.1% Tween 20 
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2.6 Measurement of reactive oxygen species (ROS) 
concentration 
Concentration of ROS was measured using the 
chemical 2,7-dichlorodihydrofluorescein diacetate 
(DCFH-DA), which reacts with cellular esterases and ROS 
to the fluorescent dichlorofluorescein (DCF), after 
diffusing into the cell. The fluorescence signal, which 
corresponds to ROS levels, was measured with FACS, 
using FITC channel at 480nm excitation and 530nm 
emission. 50mg of DCFH-DA powder was dissolved in 
10ml Dimethylsulfoxid (DMSO) and aliquots were stored 
at -20˚C in darkness. The concentration of the dye in the 
frozen stock solutions was 10mM. For positive controls a 
concentration of 500µM and 1000µM H2O2 was used. 
After harvesting and counting, 1x106 immature dendritic 
cells per 1ml culture medium were put in a 12 well plate 
(non-tissue treated, FALCON), as shown in Table 6, and 
stored in a cell culture incubator. 
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Table 6: Stimulation scheme for ROS measurement 
 
1x106 cells 
(non-
stimulated) 
1x106 cells + 
B. vulgatus 
 MOI 1 
1x106 cells + 
E. coli  
MOI 1 
1x106 cells + 
E. coli  
MOI 20 
1x106 cells + 
500µM H2O2 
 
(positive 
control) 
1x106cells + 
1000µM H2O2 
 
(positive 
control) 
1x106 cells 
without  
DCFH-DA 
(negative 
control) 
 
 
After 2h in the cell culture incubator the cells were 
inoculated with B. vulgatus mpk (MOI 1) and E. coli mpk2 
at MOI 1 and MOI 20 as shown in table 5. 500µM and 
1000µM H2O2 were added to 2 of the wells for positive 
control and 1 well was left untreated for negative control. 
1µg/ml Gentamycin per well was added to prevent bacteria 
overgrowth. After 1 hour and 16 hours of incubation in the 
cell culture incubator 7µM DCFH-DA stock solution was 
added to each well except for the negative control and cells 
were incubated further for 15min. Afterwards DCs were 
scraped off the plate, washed twice with PBS and analyzed 
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immediately with the BD LSRFortessa II (BD) cell 
analyzer. 
2.7 Proteomics run 
Unlabeled shotgun proteome analysis was 
performed on 6 samples: unstimulated (5min and 16h), B. 
vulgatus mpk stimulated (5min and 16h) and E. coli mpk2 
stimulated DCs (5min and 16h) by the core proteome 
facility at the Proteome center, University of Tübingen. 
Exact protocols for mass spectrometry is available at the 
proteome facility.  
2.8 Bioinformatics analysis and data analysis 
The raw-data obtained from the proteome analysis, 
consisting of 2 biological and 3 technical replicates for 
each experimental condition, was further assessed by Dr. 
Marius Codrea (Quantitative Biology Center (QBiC), 
Tübingen), using bioinformatics tools. Detailed protocol is 
available in the QBiC center. The process of data analysis 
is described in detail in the results section (2.3.).
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3 Results 
3.1 B. vulgatus mpk and E. coli mpk2 induce 
different TNFα, IL-6, IL-12p40 and IL-1β 
secretion profiles. 
It has previously been shown that E. coli mpk2 
stimulated DCs have differences in proinflammatory 
cytokine secretion profiles in comparison to B. vulgatus 
mpk stimulated DCs (Frick et al., 2006).  To assess 
cytokine production by BMDCs, upon stimulation with 
pathobiotic (E. coli mpk2) and symbiotic (B. vulgatus 
mpk) bacteria, murine DCs were stimulated with viable 
bacteria at MOI 1 for 16h. 16h samples were restimulated 
with E. coli mpk2 for another 16h. Culture supernatants 
were collected at time points 16h and 32h and the levels of 
TNFα, IL-6, IL-12p40 and IL-1β were determined by 
ELISA (Figure 5). 
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Figure 6: Cytokine secretion profiles of cultured murine bone 
marrow derived dendritic cells, isolated from wild type 
C57BL/6. 
Mo: Unstimulated, BV: Stimulated with B. vulgatus mpk, EC: 
Stimulated with E. coli mpk2. Stimulation, done 7 days after bone 
marrow aspiration for 16h, restimulation is done subsequently for 
another 16h. ELISA is performed with supernatants, collected from both 
stimulations. The results are representative for three independent 
experiments. Each experiment was performed in technical triplicates and 
values represent the mean ± SD of triplicates (*p< 0.05). 
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E. coli stimulation induced a high level secretion of 
inflammatory cytokines – TNFα (2635pg/ml), IL-6 
(59,8ng/ml), IL-12p40 (2510pg/ml) and IL-1β (485pg/ml). 
Upon restimulation with E. coli mpk2 the production of 
these cytokines strongly decreased, which confirms 
previous studies, showing desensitization to bacterial 
challenge (Visintin et al., 2001). Stimulation with B. 
vulgatus mpk resulted in low level secretion of 
inflammatory cytokines and after restimulation with E. 
coli mpk2 the cytokine production did not increase for 
TNFα, whereas for IL-6, IL-12p40  and IL-1β there was a 
slight increase observed, however still much lower than 
the increase in the restimulated control sample (Mo+EC). 
The untreated sample showed basal level of secretion of 
inflammatory cytokines and upon restimulation (time 
point 32h) the production increased significantly to the 
level of E. coli mpk2 stimulated DCs (time point 16h) for 
TNFα, IL-12p40  and IL-6. The data suggests that B. 
vulgatus mpk in contrast to E. coli mpk2 is less potent to 
trigger inflammatory responses in DCs and even appears 
to exert an inhibition of cytokine secretion. Cytokine 
production is one of the factors that characterizes three 
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different phenotypic states: non-stimulated, immature DCs 
(TNFαno, IL-6no, IL-12p40no and IL-1βno), B. vulgatus mpk 
stimulated, semi-mature DCs (TNFαlow, IL-6low, 12p40low 
and IL-1βlow) and E. coli mpk2 stimulated, fully mature 
DCs (TNFαhigh, IL-6high, 12p40high and IL-1βhigh). These 
results confirm previous data (Frick et al., 2006) and show 
the presence of different states of DC maturation, which 
are used for our proteomics downstream applications. 
3.2 Stimulation with B. vulgatus mpk and E. coli 
mpk2 leads to differential expression of cell 
surface markers in BMDCs. 
Frick et al. showed that B. vulgatus mpk stimulated, 
semi-mature dendritic cells exhibit a lower percentage of 
MHC-II and CD40 expression compared to E. coli mpk2 
stimulated, fully mature dendritic cells. In this experiment 
unstimulated, B. vulgatus mpk stimulated and E. coli mpk2 
stimulated DCs were analyzed 16h after stimulation for 
CD11c, MHC-II and CD40 surface expression by flow 
cytometry (Figure 7). E. coli stimulated BMDC express 
high levels of MHC-II (32,2 %) and CD40 (79,5%) and 
activated and maturated DCs. In contrast, in DCs exposed 
to B. vulgatus mpk, the expression of the two surface 
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activator markers were nearly unaffected, corresponding 
to the basal level of expression in unstimulated DCs. This 
data suggests a reduced ability of B. vulgatus mpk to 
activate and maturate DCs and further characterizes the 
semi-mature state (low percentage MHC-II and CD40) and 
the mature state (high percentage MHC-II and CD40) of 
DCs. Taken together, differential cell surface marker 
expression and proinflammatory cytokine secretion 
determine the phenotypical differences of B. vulgatus 
mpk- and E. coli mpk2 stimulated DCs, to which we refer 
as semi-mature and fully mature DCs in the following 
proteome experiments.  
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Figure 7: Expression of surface molecules by DCs upon 
stimulation with commensal bacteria. 
Unstimulated, B. vulgatus mpk stimulated and E. coli mpk2 
stimulated DCs were double stained with CD11c and either MHC-
II (A) or CD40 (B) antibodies and their expression was detected by 
FACS 16h after stimulation. The numbers indicate the percentage 
of double positive DCs for each condition. 
3.3 Proteome analysis of stimulated DCs with 
commensal bacteria. 
The effect of different bacterial colonization on 
developing colitis was previously described in mouse 
models. IL-2-/- mice, which were monocolonized with E. 
coli mpk2 developed colitis, whereas mono-association 
with B. vulgatus mpk, or co-colonization with E. coli 
    
                           
Results 
52 
 
mpk2 and B. vulgatus mpk did not induce colitis 
(Waidmann et al., 2003). This finding was further 
investigated and associated with different DC polarization 
as a result of the interaction of LP DCs, MLN DCs and 
BMDCs in vivo and in vitro with the particular commensal 
bacteria (Frick et al., 2006; Muller et al., 2008). To get a 
better understanding of the molecular basis, behind this 
complex mechanism, BMDCs were stimulated in vitro 
either with E. coli mpk2, or B. vulgatus mpk, or were 
untreated for control. Protein samples were collected 5min 
and 16h after stimulation. A non-labeled shotgun 
proteome analysis was performed on the samples for 
protein identification and relative quantitation, giving us 
the opportunity not only to detect expressed proteins but 
also to compare their expression levels between the 
samples at different time points. 
3.3.1 Experimental setup 
Bone marrow-derived DCs were stimulated either 
with B. vulgatus mpk, or E. coli mpk2, or were 
unstimulated for control. 2 biological and 3 technical 
replicates for each experimental condition were sent to the 
proteome center in Tübingen. A shotgun proteome 
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analysis was performed and 4559 peptides were identified 
in total. From those, 1358 peptides were detected in all 6 
replicates for all 3 conditions (E. coli mpk2 stimulated, B. 
vulgatus mpk stimulated and untreated DCs) at both time 
points 5min and 16h (Table 7, Case 1a). The remaining 
3201 peptides were detected in less than 6 replicates for at 
least one of the conditions. To ensure reproducible protein 
detection, we required each protein to be detected in at 
least 4 of 6 replicates for at least one condition, to be 
considered for further analysis. After removing the 
proteins, detected in 3 or less replicates, we ended up with 
780 proteins that can reliably be analyzed further. Some of 
them were detected only in one condition and therefore 
referred to as “state specific” (Table 7, Case 2) and others, 
in more than one condition, allowing pairwise comparison 
between the conditions using Student t-test (Table 7, Case 
1b).  
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Table 7: Description of different cases and statistical 
               tests used in data analysis 
 
 Definition Statistical 
tests used 
Case 1 
a) Proteins, which were 
detected in all 6 replicates, 
all 3 conditions and both 
time points 5min and 16h. 
b) Proteins, which were 
detected in more than one 
condition, in at least 4 of 6 
replicates at time point 
16h. 
ANOVA 
(Tukey) 
 
 
Student T-
test 
Case 2 Proteins, which were detected only 
in one condition, in at least 4 of 6 
replicates. 
Ø 
 
3.3.2 Determining differentially regulated proteins 
The mean intensity values for each protein at time 
points 16h and 5min were used to perform specific 
statistical tests for each of the cases, described above. Case 
1a proteins were pairwise compared among the 3 
conditions using ANOVA (Tukey) as a statistical tool, 
which considers protein intensity values at both time 
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points. There were 162 proteins with p< 0.05 for at least 
one of the 3 pairs. ANOVA (Tukey) was impossible to use 
in Case 1b, because of the variable detection of a protein 
in the different conditions and time points. Therefore a 
student T-test was performed, comparing pairwise protein 
intensity values only at time point 16h. All the Case 1b 
proteins with p< 0.05 for at least one of the 3 pairs were 
considered significant in terms of differential regulation 
and were used for further analysis. Case 2 proteins were 
detected only in one condition and thus taken as 
differentially expressed per default. Altogether, after 
assessing the data with statistical tools, we were able to 
filter 254 significant proteins in total, which are going to 
be used in the further data mining.  
3.3.3 Clustering of the differentially regulated proteins 
In order to get a general understanding of the data 
in terms of functional classification, the 254 differentially 
regulated proteins were uploaded in the DAVID 
annotation software. DAVID software uses integrated 
databases and analytical tools to extract biological 
meaning from large proteome data, discovering functional 
groups, enriched in the uploaded proteins dataset (Huang 
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da, Sherman, & Lempicki, 2009). Proteins were 
automatically annotated at medium classification 
stringency to diverse biological processes, which were 
considered as subclusters to constitute 14 major biological 
clusters (Figure 8).  
 
 
Figure 8: Distribution of proteins, annotated to major cellular 
processes, ilustrating the clustering of the proteome data with 
DAVID annotation software. 
254 differentially regulated proteins, preselected with statistical tools, 
were annotated according to Gene Ontology database to diverse 
biological processes, organized in 14 major biological clusters, shown in 
different colors. Numbers indicate the distribution in percentage of all 
significant proteins among the different clusters. 
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The purpose of this illustration was to provide a 
general overview of the data in terms of distribution of the 
254 differentially regulated proteins over major biological 
processes. Five functional classes stand out of the data, 
containing 66% of all proteins: Immunity/Inflammation 
(16%), Stress response (9,5%), Protein fate (15,9%), 
Transcription/Translation (11,2%) and Metabolism 
(13,7%). The remaining 34% are similarly distributed over 
9 other functional clusters.  
3.3.4 Detailed visualization of protein expression at 
multiple levels of detail 
Using the annotation results from the DAVID 
software, described in section 3.3., we aimed to provide 
another level of detail, showing subclusters of the major 
biological processes and even single proteins, which are 
differentially regulated between E. coli mpk2 stimulated, 
mature DCs, B. vulgatus mpk stimulated, semi-mature 
DCs and unstimulated, immature DCs in order to 
characterize more precisely the different maturation states 
of a dendritic cell. We chose Voronoi treemaps as the 
visualization technique of our proteome data (Bernhardt, 
Michalik, Wollscheid, Volker, & Schmidt, 2013), because 
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it enables the comparison of expression level differences 
and patterns in multiple levels of detail, depending on the 
interests of the researcher. Our data is displayed in 3 layers 
of increasing detail. The first layer (Figure 9) visualizes 14 
major cellular processes on a 2D image, where every 
polygon represents a process. The second layer (Figure 9) 
consists of smaller polygons within the big polygons, 
representing the subprocesses within a major biological 
process. The third level (Figure 9) shows a complete, 
highly detailed picture of the data, where each cell 
corresponds to a single protein. In order to compare 
protein expression, the ratios of the mean intensity values 
for each protein at time point 16h were calculated pairwise 
and averaged to be assigned to a specific color (Figure 9). 
All pair combinations were considered: E. coli mpk2 
stimulated DCs versus unstimulated DCs, which should 
represent the full maturation process (Figure 9A); B. 
vulgatus mpk stimulated DCs versus unstimulated DCs, 
which should represent the semi-maturation process 
(Figure 9B) and B. vulgatus mpk stimulated versus E. coli 
mpk2 stimulated DCs, which should report the differences 
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in proteome of semi-mature and fully mature dendritic 
cells (Figure 9C).  
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 A      B. vulgatus mpk stimulated vs unstimulated DCs 
 
Level 1: Major processes 
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 A      B. vulgatus mpk stimulated vs unstimulated DCs 
 
Level 2: Subrocesses 
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 A      B. vulgatus mpk stimulated vs unstimulated DCs 
 
Level 3: Single proteins 
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B         E. coli mpk2 stimulated vs unstimulated DCs 
 
Level 1: Major processes 
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B         E. coli mpk2 stimulated vs unstimulated DCs 
 
Level 2: Subrocesses 
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B         E. coli mpk2 stimulated vs unstimulated DCs 
 
Level 3: Single proteins 
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C           B. vulgatus mpk stimulated vs E. coli mpk2 
stimulated DCs 
 
Level 1: Major processes 
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C           B. vulgatus mpk stimulated vs E. coli mpk2 
stimulated DCs 
 
Level 2: Subrocesses 
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C           B. vulgatus mpk stimulated vs E. coli mpk2 
stimulated DCs 
 
Level 3: Single proteins 
Figure 9: Differential protein expression of distinct DC 
maturation states, visualized by Voronoi treemaps. 
The proteome data is presented as color 2D images at different levels of 
detail: major functional processes (represented by the biggest polygons); 
subprocesses (smaller polygons within the biggest polygons) and single 
proteins (represented by the smallest polygons).  Protein expression 
differences were calculated in a pairwise manner using the mean intensity 
values for each protein to compare between the three conditions, 
considering all the possible combinations: (A) B. vulgatus mpk stimulated 
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DCs vs control; (B) E. coli mpk2stimulated DCs vs control and (C) B. 
vulgatus mpk stimulated vs E. coli mpk2 stimulated DCs. Color represents 
expression level differences. Red: increased expression, Blue: decreased 
expression, Light grey: No change in expression, Dark grey: not detected 
in the particular pair. Color intensity is adjusted to the expression level 
difference on log2 scale. Brighter colors indicate small, darker colors - 
strong expression level differences. 
 
The visualization with Voronoi treemaps provides a 
general look on affected cellular processes as a starting 
point for the analysis of our shotgun proteome results. As 
expected, upon stimulation with bacteria, a dynamic 
regulation is seen between different dendritic cell 
maturation states. In general, a total of 206 proteins are 
regulated during semi-maturation (69 up- and 137 
downregulated) (Figure 9A), 207 proteins are regulated 
during full-maturation (90 up- and 117 downregulated) 
(Figure 9B), and 182 proteins (78 up- and 104 
downregulated) are differentially regulated between semi-
mature and fully mature DCs (Figure 9C). On a more 
specific scale, in B. vulgatus stimulated DCs compared to 
control, we see a strong downregulation in most of the 
major biological clusters. An exception is the cluster 
Apoptosis, where all 3 subclusters are upregulated in B. 
vulgatus stimulated DCs. Furthermore, it is important to 
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mention, that there are many subprocesses in light grey, 
especially in the cluster Immunity/Inflammation, meaning 
that, on average, there is little to no change in protein 
expression in this major biological cluster, compared to the 
unstimulated control DCs. However, in 
Immunity/Inflammation, there is differential regulation to 
some extent in single subprocesses. Subclusters such as 
“leukocyte activation”, “T-cell differentiation” and 
“regulation of T-cell activation” are downregulated, 
whereas “inflammatory response”, “regulation of cytokine 
production”, “regulation of leukocyte mediated immunity” 
“antigen processing and presentation” are upregulated in 
B. vulgatus stimulated DCs. Additionally, several 
important clusters, belonging to Migration such as 
“chemotaxis” and “leukocyte migration are also 
upregulated in B. vulgatus stimulated DCs compared to 
control. Taken together, our results confirm previous 
statements, that B. vulgatus stimulated DCs are a distinct 
type of DCs, referred to as “semi-mature DCs”, showing 
that they are different from unstimulated BMDCs. 
Furthermore, our results suggest, that semi-mature DCs 
have a decreased ability to activate immune cells, however 
    
                           
Results 
71 
 
they may initiate a mild pathogenic response, 
characterized with cytokine production, antigen 
processing and presentation, as well as increased 
migration. In contrast to B. vulgatus stimulated DCs, E. 
coli stimulated DCs show a strong upregulation of most 
major biological processes, compared to control. This 
upregulation is striking for the cluster 
“Immunity/Inflammation”, where almost every 
subprocess within the big process is upregulated. The 
majority of subprocesses related to “Stress response”, 
“Migration” and “Apoptosis” are also strongly 
upregulated. Collectively, our observations lead to the 
conclusion, that E. coli stimulated DCs induce full 
maturation of BMDCs, characterized by higher expression 
of proteins related to inflammation, cell stress, apoptosis 
and migration compared to immature DCs, consistent with 
previous observations and confirming the ELISA and 
FACS results described above. The last Voronoi treemap 
shows a direct comparison between B. vulgatus stimulated, 
semi-mature DCs and E. coli stimulated fully mature DCs. 
There is a widespread downregulation observed in the 
cluster Immunity/Inflammation for B. vulgatus stimulated 
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semi-mature DCs. Immunity cluster is of special 
importance to us, since it harbors important proteins with 
potent immunoregulatory effects such as IL-1α, IL1-β, IL-
12p40, CD40, NDRG1 and CCL5, all of which are 
downregulated in B. vulgatus stimulated DCs. Noteworthy 
is the fact, that “response to cellular stress” and “response 
to DNA-damage” are upregulated in B. vulgatus 
stimulated DCs, despite the low induction of 
inflammation. This seemingly contradictory finding is 
further discussed in the following subsection, where we 
investigate the “stress response” cluster in detail. Of 
particular interest to us are anti-stress proteins with 
potential protective properties, such as Phb-1 and TGFβ, 
which are both upregulated in B. vulgatus stimulated DCs. 
Furthermore, “proteolysis” and “regulation of 
transcription” are downregulated, whereas other 
subclusters, which belong to “Transcription/Translation”, 
“Chromosome organisation”, “Protein fate” and 
“Apoptosis” are upregulated in B. vulgatus  stimulated 
semi-mature DCs. Upon a detailed look at single proteins, 
an upregulation of Akt1 is to be mentioned as an important 
kinase, involved in many subprocesses, including cell 
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growth and differentiation, transcription, translation and 
cell cycle progression. Our results show that the 
phenotypical differences observed between B. vulgatus 
and E. coli stimulated samples are reflected on a proteome 
level as well. B. vulgatus stimulation results in global 
downregulation of major pro-inflammatory factors, as well 
as upregulation of protective factors and proteins with 
tolerogenic properties. Our results provide a multilayered, 
detailed picture of protein expression patterns that are 
specific for semi-mature and fully mature DCs and crucial 
for understanding their functional and phenotypical 
differences. 
3.4 Semi-mature DCs show higher expression of 
antioxidant and cytoprotective proteins, 
compared to fully mature dendritic cells. 
After creating an overview picture of the whole data 
we took a closer look into single clusters, aiming to find 
anti-inflammatory proteins, which are differentially 
expressed in B. vulgatus stimulated DCs in comparison to 
E. coli mpk2 stimulated DCs. We focused on the 
differences in proteins clustered in stress response, 
comparing their expression between B. vulgatus 
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stimulated and E. coli stimulated cells 16h after 
stimulation (see Figure 10). 
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Figure 10: Expression ratios of proteins, involved in stress 
response, in comparison between semi-mature and fully 
mature DCs. 
(A) Ratios of mean intensity values were calculated at time point 16h 
for stress response proteins, detected in B. vulgatus stimulated, semi-
mature DCs (B.v.) and E. coli stimulated, fully mature DCs (E.c.). 
All the proteins in red are  expressed in higher levels in fully mature 
DCs, proteins in blue are expressed in higher levels in semi-mature 
DCs. (B) Proteins, expressed only in E. coli stimulated mature 
dendritic cells (red) or only in B. vulgatus stimulated semi-mature 
DCs (blue). 
 
State specific proteins 
Expressed only in 
E. coli stimulated 
DCs 
Expressed only in 
B. vulgatus  
stimulated DCs 
Hsp70-1 Glns 
Arg1 
Stat5b 
Ifi75 
Ccl5 
Mcl1 
 
B 
    
                           
Results 
77 
 
Our proteome results indicate a higher expression of 
proteins belonging to the stress response cluster in E. coli 
stimulated DCs than in B. vulgatus mpk stimulated DCs. 
State specific proteins, shown in the table above (Figure 
10B) contribute to this statement as well, given the number 
of single proteins exclusively expressed in E. coli- mpk2 
compared to B. vulgatus mpk stimulated DCs. On one 
hand, in the presence of E. coli, dendritic cells start to 
produce high amounts of inflammatory cytokines such as 
IL-1α, IL-1β. This finding is in line with the ELISA results 
(see Figure 6), obtained previously. Furthermore, Stat 5a, 
Stat 5b, Hsp-70, Myd88, CD14, CD44, CD180, HLA-I, 
Aif and Casp1, which are well known proteins, involved 
in inflammation, cell damage and cell death, are 
upregulated in E. coli stimulated DCs. On the other hand, 
B. vulgatus stimulated, semi-mature dendritic cells express 
a high amount of proteins related to protection from 
oxidative stress e.g. Prohibitin (Phb-1), Superoxide 
dismutase (Sod1), Glutathione-S-Tramsferase omega-1 
(Gsto1), Thioredoxin (Txn), Glutamate-cysteine ligase 
(Gclm). Moreover, proteins involved in a tolerogenic DC 
response e.g. TGFβ are upregulated in semi-mature DCs. 
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This data confirms the potential of E. coli to induce a 
strong inflammatory stress response and cell death in 
BMDCs, whereas B. vulgatus stimulated DCs appear to be 
able to induce peripheral tolerance via TGFβ and to deal 
better with stress, in particular with reactive oxygen 
species (ROS), indicated by increased production of 
antioxidant enzymes.  
3.5 Prohibitin (Phb1) amount is slightly increased in 
B. vulgatus mpk stimulated samples, compared to 
E. coli mpk2 stimulated samples. 
Based on a previous study (Theiss, Vijay-Kumar, et 
al., 2009) we selected Phb-1 as an important candidate to 
validate, as it is known to play an important role in ROS 
metabolism. It acts as a modulating protein to promote 
Nrf2 accumulation in the nucleus and thus production of 
AREs (Antioxidant response elements), which are highly 
expressed in B. vulgatus mpk stimulated DCs i.e. Sod1, 
Gsto1, Gclm (see Figure 10A). To assess the amount of 
Phb-1 produced, western blotting was performed and 
compared with proteome data (Figure 11). 
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Figure 11: Prohibitin expression of semi-mature and fully 
mature DCs. 
Western blot results on Prohibitin expression in B. vulgatus mpk 
stimulated (B.v.) and E. coli mpk2 stimulated (E.c.) bone marrow 
derived dendritic cells 16h (16´) after stimulation.The house-keeping 
protein expression of β-actin was included as loading control. (B)  
Proteome results for Prohibitin in B. vulgatus mpk stimulated and E. coli 
mpk2 stimulated samples at time point 16h, illustrated by bar graph using 
the mean  intensity values of the protein, obtained from the proteome 
data. E. coli mpk2 stimulated DCs show low expression of the 
antioxidant protein in both cases. 
 
As the differences between the samples were too subtle to 
detect by eye, optical band density values were measured 
with ImageJ software and Phb1 expression was 
normalized according to the values of the house-keeping 
protein β-actin (Figure 11A). Results were compared to the 
intensity values for Prohibitin, obtained from the mass 
spectrometric reads (Figure 11B). The comparison of 
western blot data with proteome data shows a high degree 
of conformity in terms of expression values. In both 
western blot data and proteome data, semi-mature DCs 
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show a slightly higher amount of the antioxidant Prohibitin 
at time point 16h, suggesting a better protection against 
oxidative substances in comparison to fully mature DCs. 
We acknowledge that the expression level difference we 
observed is very small, however for key regulatory 
molecules such as Phb1, such small differences can have a 
bigger impact on downstream pathways.   
3.6 DCs stimulated with pathobiotic bacteria harbor 
increased amounts of ROS, compared to DCs 
stimulated with symbiotic, protective bacteria. 
As it is known that ROS imbalance plays an 
important role in inflammatory processes and in particular 
colitis (A. Wang et al., 2014), we aimed at investigating 
ROS production in DCs upon stimulation with pathobiotic 
and symbiotic bacteria. Viable BMDCs were stimulated 
with B. vulgatus mpk at MOI 1 and E. coli mpk2 at MOI 1 
and MOI 20 for 1h and 16h. DCFH-DA reacts with ROS 
to produce the fluorescent DCF, which was measured by 
FACS using the FITC-channel, 1h (Figure 12A) and 16h 
(Figure 12B) after stimulation. The level of DCF 
corresponds to the amount of ROS in the cells. 
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Figure 12: Production of reactive oxygen species (ROS) upon 
stimulation with commensal bacteria. 
ROS amount in the cytoplasm was measured with FACS in unstimulated, 
B. vulgatus stimulated (MOI 1) and E. coli stimulated (MOI 1 and MOI 
20) bone marrow derived dendritic cells 1h (A) and 16h (B) after 
stimulation, using DCFH-DA as a fluorescence marker. (C) Untreated 
DCs were used as negative control and two positive controls with 500µM 
and 1000µM H2O2 were also included. Representative histograms are 
shown from 2 independent experiments. DCF signal intensity, which 
corresponds to ROS amount in the cytoplasm, is captured on the FITC 
channel. 
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The negative control showed negligible to no amount of 
ROS (109) and increasing amounts of H2O2 in the positive 
controls gave rise to increased FITC-signals, suggesting 
that the assay is reliable in quantifying ROS levels. 
Immature DCs, stimulated with E. coli showed the highest 
amount of ROS at both time points. Whereas at time point 
1h there was a minimal difference between MOI 1 and 
MOI 20, at time point 16h the ROS production by DCs 
stimulated with E. coli mpk2 at MOI 20 was considerably 
higher, indicated by a high mean fluorescence value 
(2399). B. vulgatus stimulated DCs showed slight increase 
of ROS (551), nevertheless still close to the basal level of 
the unstimulated sample (402). Over time a slight increase 
in the mean fluorescence intensity in both unstimulated 
and B. vulgatus stimulated DCs was observed but not as 
high as the increase in E. coli mpk2 stimulated DCs at MOI 
1 and 20. In conclusion, we demonstrated that E. coli 
challenge results in higher amount of ROS accumulation 
in the DC cytoplasm, compared to stimulation with the 
symbiotic B. vulgatus. 
    
                           
Results 
83 
 
3.7 E. coli stimulation of BMDCs leads to higher 
surface expression of the migration marker 
CCR7. 
Stimulation with E. coli in vivo induces increased 
DC migration towards lymph node, whereas B. vulgatus  
stimulated DCs showed reduced ability to migrate (Muller 
et al., 2008). To assess DC migration upon stimulation 
with pathobiotic E. coli mpk2 and symbiotic B. vulgatus, 
BMDCs were inoculated with viable bacteria at MOI 1 for 
16h. Surface expression of chemokine receptor CCR7 was 
measured by FACS (Figure 13).  
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Figure 13: Expression of CCR7 by DCs upon stimulation with 
commensal bacteria. 
FACS analysis of CCR7 expression in unstimulated, B. vulgatus 
stimulated (MOI 1) and E. coli stimulated (MOI 1) bone marrow derived 
dendritic cells at time point 16h. Cells are double stained with CCR7 and 
a specific DC-marker - CD11c. The percentage of double positives cells 
(> 103 on the x-axis and >103 on the y-axis) in each condition is shown at 
the bottom right corner of the corresponding graph. E. coli stimulated DCs 
demonstrate the highest CCR7 expression. 
 
E. coli mpk2 stimulated DCs showed increased surface 
expression of the migration marker CCR7, indicated by 
population shift and population size (89,6%). On the other 
hand, stimulation with B. vulgatus mpk did not lead to a 
major increase in CCR7 expression. CCR7 amount on the 
cell surface of B. vulgatus mpk stimulated DCs was more 
close to that of unstimulated control samples (56.6% vs 
42.5%). Additionally, our proteome results indicate 
upregulation of migration related proteins in E. coli mpk2 
stimulated mature DCs, compared to B. vulgatus mpk 
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stimulated DCs such as Fn1, Actn4, Myh9, Coro1, Rtn4 
(Figure 14). In our proteome experiment, CCR7 and CCL5 
were detected only in E. coli mpk2 stimulated DCs and not 
in the other two conditions. Important for us was the 
regulation of CCR7, as it is a crucial chemokine for DCs 
migration and it was previously shown to be upregulated 
in fully-mature DCs, compared to semi-mature DCs 
(Muller et al., 2008).  Taken together, our proteome data 
and FACS results suggest a reduced potential of B. 
vulgatus mpk to induce migration in immature DCs, 
compared to E. coli mpk2.  
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Figure 14: Expression ratio of proteins, involved in 
migration, in comparison between semi-mature and fully 
mature DCs. 
Ratios of mean intensity values at time point 16h were calculated for 
proteins detected in B. vulgatus mpk stimulated semi-mature DCs (B.v.) 
and E. coli mpk2 stimulated fully mature DCs (E.c.). The proteins below 
1 (red) are more expressed in fully mature DCs, those above 1 (blue) are 
more expressed in semi-mature DCs. Expression of migration related 
proteins is strongly increased in E. coli mpk2 stimulated DCs, compared 
to B. vulgatus mpk stimulated DCs. CCR7 and CCL5 were detected only 
in E. coli mpk2 stimulated mature dendritic cells. 
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4 Discussion 
The main findings of this study are:  
(i) E. coli has strong inflammation inducing 
potential, whereas B. vulgatus shows 
inflammation suppressive properties, 
mediated by inhibition of cytokine secretion.   
(ii) B. vulgatus, compared to E. coli has reduced 
ability to activate and maturate DCs, 
characterizing two distinct DC maturation 
states: semi-mature state (TNFαlow, IL-6low, 
IL-12p40low and IL-1βlow; low percentage 
MHC-II+ and CD40+ cells) and mature state 
(TNFαhigh, IL-6high, IL-12p40high and IL-
1βhigh; high percentage MHC-II+ and CD40+ 
cells). 
(iii) Colitogenic E. coli demonstrates higher 
potential to induce inflammation and 
migration in DCs, whereas B. vulgatus 
stimulated DCs exert a regulatory and 
dampening effect on inflammation and 
migration.    
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(iv) Colitogenic E. coli stimulation leads to 
increased accumulation of ROS in BMDCs, 
an effect not seen in B. vulgatus stimulated 
samples. 
(v) Semi-mature dendritic cells appear to have 
activated countermeasures to oxidative 
stress, as members of Keap1-Nrf2 pathway 
are upregulated. 
(vi) Western blot results show that E. coli 
stimulated samples, compared to B. vulgatus 
stimulated and control samples, express less 
Phb1 in line with our proteome results. 
In our study we investigate the effect of B. vulgatus mpk 
and E. coli mpk2 on the activation and maturation of DCs, 
the major antigen-presenting cells in the gut. Furthermore, 
we are interested in defining specific protein expression 
patterns, which characterize different maturation states of 
DCs. Finally, we are curious about how these maturation 
states affect and modulate intestinal inflammation in IBD 
and what parallels can we draw from our results to the 
clinical observations.   
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The two gram-negative commensal bacteria we used 
to stimulate BMDCs have already been shown to have 
different influences on gut homeostasis and developing 
colitis in mammalians. In HLA-B27 transgenic rats, B. 
vulgatus  induced severe colitis, while E. coli did not 
(Rath, Wilson, & Sartor, 1999). In contrast, our group 
showed that in IL-2-deficient mice kept under SPF 
conditions monocolonization with E. coli led to colitis, 
whereas B. vulgatus monocolonization did not lead to 
disease. Interestingly, co-colonization with E. coli and B. 
vulgatus  did not lead to colitis as well, suggesting that B. 
vulgatus  has the potential to protect from developing the 
disease (Waidmann et al., 2003). This contradiction 
between the two research groups can stem from various 
crucial differences in experimental setting. Most 
importantly, the experiments are performed on two 
different species (mouse vs rat) using different strains of 
the same bacteria (e.g. B. vulgatus vs B. vulgatus mpk). 
The B. vulgatus strain, used by Rath et al. was received as 
a gift from another group that isolated it from a guinea pig 
with carrageenan-induced colitis. In comparison, 
Waidmann et al. performed the in vivo experiments in 
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germ free (GF) mice with mass spectrometry proven E. 
coli mpk2 and B. vulgatus mpk. Equally important is the 
environment the animals were kept in and differences 
between animal facility of rat and mice, as well as 
substantial differences of gut microflora between these 
animals. 
As dendritic cells are an important link between 
microbiota and adaptive immune system, it was interesting 
to see how gut commensal bacteria interact with them. 
Frick et al. (2006) found that in vitro stimulation of 
BMDCs with B. vulgatus mpk leads to non-responsiveness 
of the cells to further E. coli stimulus, indicated by reduced 
TNFα and IFNγ secretion and reduced Th1 polarization, 
compared to BMDCs, stimulated only with E. coli. They 
argued that B. vulgatus is able to drive a DC into a specific 
state, non-responsive to a second stimulus, which was 
referred to as “semi-mature state”. It was further 
characterized by low secretion of inflammatory cytokines 
and low expression of surface activation markers. In 
contrast, stimulation with E. coli mpk2 led to activation 
and full maturation of DCs, characterized by high 
production of inflammatory cytokines and significant 
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increase in DC surface activation marker expression, such 
as CD40 and MHC-II. Moreover, fully mature DCs 
showed increased migration towards MLN, where they 
were capable of polarizing TH cells into TH1 direction 
(Frick et al., 2006; Muller et al., 2008). These different 
phenotypes of DCs have already been described and 
termed previously in the literature and were thought to 
play an integral role in maintaining tolerance or immunity 
in the mice gut (Lutz & Schuler, 2002). 
Our FACS and ELISA results correspond to these 
findings confirming the presence of three different 
phenotypical states in our samples:  immature DCs 
(TNFαno, IL-6no, IL-12p40no and IL-1βno; low percentage 
MHC-II+ and CD40+), semi-mature DCs (TNFαlow, IL-
6low, IL-12p40low and IL-1βlow; low percentage MHC-II+ 
and CD40+) and fully mature DCs (TNFαhigh, IL-6high, IL-
12p40high and IL-1βhigh; high percentage MHC-II+ and 
CD40+). We chose to use bone marrow-derived dendritic 
cells (BMDCs) in our experiments, because it is a well-
established system to study DCs in vitro. Only cell cultures 
with CD11c+ cell abundance more than 80% were 
considered for experiments. Further purification of the 
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cells with cell sorting methods i.e. magnetic sorting and 
FACS sorting were tried, but were unsuitable, because the 
method itself stresses and maturates DCs.  
After performing a shotgun proteome analysis, three 
different pairwise comparisons were made (i.e. B. vulgatus 
mpk stimulated vs. unstimulated DCs; E. coli mpk2 
stimulated vs. unstimulated DCs and B. vulgatus mpk 
stimulated vs. E. coli mpk2 stimulated DCs). Differences 
in protein expression patterns were illustrated by Voronoi 
treemaps in multiple levels of detail. Looking at the first 
and second levels, a researcher can have an overview of 
the data. If there are many upregulated or downregulated 
subclusters in one major biological process (e.g. 
Immunity/Inflammation), we would spotlight this major 
cluster as potentially characteristic for one of the DC 
maturation states. After determining the focus, looking at 
the overview layers, a researcher can now have a look at 
the third and last level, which provides the most detailed 
picture of our data. At this layer, expression levels of each 
protein can be seen explicitly and it is possible to draw 
tentative hypotheses using such data, however one should 
be wary and consider the interactions with other proteins 
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to determine the exact role of a protein in that particular 
cluster. Akt1, for instance, is seen in the proteome data as 
upregulated in B. vulgatus mpk stimulated DCs. It is a 
multifunctional kinase, which plays a role in numerous 
biological processes e.g. Growth & Glucose metabolism, 
Cell cycle & survival, Protein synthesis, etc. (see Figure 
15). It may inhibit or stimulate other proteins and thus have 
a different influence on major biological functions. Hence, 
to determine the exact role of a protein in DC maturation, 
it must be kept in mind that proteins have diverse roles in 
different pathways and that they can interact with each 
other in an unpredictable manner. This information cannot 
be represented in our Voronoi treemaps, therefore more 
analysis on a pathway level should be performed, together 
with the confirmation of outcomes.   
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Figure 15: Akt1 signaling pathway 
The image is adopted from (Emamian, 2012). An example for 
the variety of different functions and interactions a protein can 
have. 
Our proteome catalogue represents an important starting 
point in the data mining of this proteome experiment. With 
the guidance of our visualization, we focus on clusters and 
subclusters that are particularly relevant to us and analyze 
them further.   
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One of the clusters we focused on was 
“Immunity/Inflammation”, because it is one of the most 
differentially regulated clusters between the 3 pairwise 
comparisons. All subclusters, belonging to this major 
process are upregulated in E. coli stimulated DCs, 
compared to unstimulated and B. vulgatus mpk stimulated 
DC. Hence, “Immunity/Inflammation” is a distinctive 
cluster for mature DCs and therefore a good candidate for 
further investigation. Moreover, this cluster harbors 
important proteins which are capable of modulating 
intestinal inflammation. Pro-inflammatory proteins i.e. 
IL1-β, IL-12p40, CD40 were upregulated in E. coli 
stimulated mature DCs compared to immature and semi-
mature DCs. IL1-β and IL-12p40 as well as CD40 were 
previously shown in our results to be highly expressed 
upon maturation of DCs using ELISA (Figure 6) and 
FACS (Figure 7). Furthermore, these proteins are very 
well known in the literature for their pro-inflammatory 
properties. CD40 is a cell surface protein known to be 
involved in the maturation of DCs and in inflammation 
processes. Its function has been thoroughly discussed in 
the review by (Ma & Clark, 2009). IL-12p40 is a pro-
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inflammatory cytokine, secreted from APCs i.e. DCs, 
which is believed to induce pathogenic T-helper cells 
polarization and tissue inflammation in response to 
microbial components (Krummen et al., 2010). It plays a 
crucial role in various autoimmune diseases, including 
inflammatory bowel disease (Croxford, Kulig, & Becher, 
2014; Fuss et al., 2006; Gee, Guzzo, Che Mat, Ma, & 
Kumar, 2009; Parronchi et al., 1997). Another important 
mediator of inflammation and host response to infection is 
IL-1β. It is reported to be released by DCs, monocytes or 
macrophages after stimulation with pathogen-associated 
molecular pattern molecules (PAMPs) or damage-
associated molecular pattern molecules (DAMPs) (Lotze 
et al., 2007). The interaction with a pathogen activates 
Caspase-1, which cleaves the inactive pro-IL-1β to be 
subsequently released into the extracellular matrix as 
biologically active IL-1β (Eder, 2009). Strong interaction 
with the inflammasome as a mechanism for induction of 
IL-1β secretion has been reported by many researchers 
(Aguilera, Darby, & Melgar, 2014; Church et al., 2008). 
Moreover, IL-1β has been shown to be a pro-inflammatory 
cytokine in many diseases including IBD and various 
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autoimmune disorders (Dinarello, 1996; Gionchetti et al., 
1992). All those aforementioned proteins are detected in 
our proteome experiment (Table 6). IL-1α, IL-1β and 
Casp1 are upregulated in E. coli stimulated mature DCs 
compared to B. vulgatus mpk stimulated semi-mature 
DCs, suggesting that E. coli mpk2 is capable of inducing 
an inflammatory response via stimulation of the 
inflammasome. We argue that activation of the 
inflammasome may play an important role in DC-
maturation process and tissue inflammation in IBD.  
Another central factor of inflammation is the TLR 
signaling system. TLRs represent a key mechanism of DCs 
to sense pathogens and initiate appropriate immune 
response (Akira, Uematsu, & Takeuchi, 2006; Medzhitov 
et al., 1997). As LPS is a vital component of the outer 
membrane of Gram-negative bacteria (i.e. E. coli and B. 
vulgatus), an interaction with TLR-4 takes place. 
LPS/TLR4 downstream signaling can be divided in 
MyD88-dependent and MyD88-independent pathway (Lu 
et al., 2008). Activation of the first triggers series of 
events, including NFκB release, which leads to the 
transcription of multiple pro-inflammatory genes 
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including the cytokines mentioned before (i.e. IL1-β, IL-
12p40) (O'Neill, 2006). Furthermore, LPS recognition is 
promoted by LBP and CD14 (O'Neill, 2006). MyD88 and 
CD14 were detected in our proteome experiment and 
shown to be upregulated in E. coli stimulated mature DCs, 
compared to immature and semi-mature DCs. Together 
with the upregulated pro-inflammatory cytokines, we 
show that activation of TLR4 via MyD88 is a distinctive 
feature of mature DCs in response to a potent pathogenic 
organism. 
Furthermore, using our proteomics catalogue, 
researchers can search for single proteins which are less 
investigated in the context of DC differentiation and 
intestinal inflammation. Ship1 (SH2 domain-containing 
inositol 5'-phosphatase 1), which is upregulated in B. 
vulgatus  stimulated DCs, has been recently shown to 
protect from colitis (Fernandes, Iyer, & Kerr, 2013) but 
has never been related to the maturation processes of DCs. 
C/EBPβ (CCAAT-enhancer-binding protein β), another 
less known protein, which is upregulated in B. vulgatus  
stimulated DCs, is a transcription factor responsible for the 
secretion of various cytokines. However its involvement 
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in DC maturation and relevance to inflammatory diseases 
have not been studied well. Our data can be used as a 
starting point for discovering such new proteins, which 
may play a crucial role in DC maturation or inflammation. 
The next focus of our study was placed on processes 
related to migration. This major biological function of DCs 
is very well studied in the context of inflammation and DC 
maturation process (Alvarez et al., 2008; Johnson & 
Jackson, 2014; Stock, Napolitani, & Cerundolo, 2013; 
Teijeira et al., 2014). Our proteome data and FACS 
analysis of CCR7 indicate higher migratory capability of 
E. coli mpk2 stimulated, fully mature DCs, in line with 
aforementioned studies and Muller et al. (2008). 
Subclusters and single proteins (e.g. Fn1, Actn4, Myh9, 
Coro1 and Rtn4), included in the migration cluster are 
upregulated in E. coli stimulated DCs compared to B. 
vulgatus mpk stimulated and unstimulated DCs. 
Furthermore, the surface expression of CCR7, detected by 
FACS, has significantly increased after stimulation with E. 
coli mpk2. B. vulgatus mpk did not remarkably increase 
CCR7 expression, confirming previous data (Muller et al., 
2008). In our proteomics experiment, CCR7 is detected 
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only in E. coli mpk2 stimulated DCs. It may be due to the 
fact that its abundance in semi-mature and immature DCs 
was too low to be detected by the mass spectrometer. 
CCR7 is a crucial chemokine for the controlled migration 
properties of DCs. Without this chemokine, DCs are 
unable to find their way through lymphatic vessels and to 
enter regional lymph nodes (Forster et al., 1999; MartIn-
Fontecha et al., 2003; Saban, 2014). DC mobilization 
signals, including upregulation of CCR7, are shown to be 
induced primarily in the presence of pro-inflammatory 
cytokines. The importance of IL-1β and TNFα for DC 
migration has been indisputably demonstrated in 
experiments, by neutralizing them (Cumberbatch & 
Kimber, 1995) and in mice deficient for TNFα type II 
receptors (Cumberbatch & Kimber, 1995), IL-1 type 1 
receptor (Cumberbatch, Dearman, & Kimber, 1999) and 
caspase-1 (Antonopoulos et al., 2001). The mechanism(s), 
by which these inflammatory cytokines induce migration 
include altered expression of adhesion molecules and 
chemokine receptors (e.g. CCR7) on DCs. All 
aforementioned cytokines were shown to be upregulated 
in fully mature DCs in the results of our proteomics 
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experiment. On the other hand, it has been shown that DCs 
can migrate in the absence of inflammatory stimuli (Brand, 
Hunziker, & Braathen, 1992; Bujdoso, Hopkins, Dutia, 
Young, & McConnell, 1989; Tomura et al., 2008), 
however signals that induce this “spontaneous” migration 
remain cryptic. Assessing single proteins belonging to 
migration cluster may give more insights on this issue. So 
far in our proteome analyses we have focused on two main 
issues. First, in our data and our experimental setting we 
have confirmed the presence and the regulation of 
inflammation/migration related factors that have been 
consistently described in the literature. Second, we have 
provided data on many proteins that are differentially 
expressed in distinct DC phenotypes, which are not 
investigated so far in a DC maturation/ IBD context. These 
proteins can be the focus of further efforts aiming at 
clarifying their roles in IBD. 
Our next focus were the proteins included in the 
stress response cluster. Many of the proteins we have 
discussed before in the context of inflammation are also 
present in this cluster, due to multiplicity of protein 
functions and overlapping processes between stress 
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response and inflammation. Nevertheless, there were 
several subclusters related to protection from stress, which 
were upregulated in B. vulgatus mpk stimulated DCs. 
Expression patterns, belonging to these subclusters were 
of specific importance for us, since these patterns may be 
characteristic for the semi-mature state of DCs. A closer 
look at individual proteins revealed upregulation of TGFβ 
in B. vulgatus mpk stimulated DCs. There is an increasing 
body of evidence that TGFβ secretion of DCs plays a 
major role in the development of Foxp3+ Treg cells and 
induction of tolerance (Belkaid & Oldenhove, 2008; 
Coombes et al., 2007; Coquerelle & Moser, 2008; Li, 
Wan, Sanjabi, Robertson, & Flavell, 2006). Many types of 
APCs are capable to convert naïve T-cells to Foxp3+ Treg 
cells, however DCs appear to be more efficient (Yamazaki 
et al., 2003). It is also reported that the status of activation 
of dendritic cells has a different influence on their capacity 
to induce Treg response (Belkaid & Oldenhove, 2008; 
Bettelli et al., 2006; Veldhoen, Hocking, Atkins, Locksley, 
& Stockinger, 2006). TGFβ deficiency has been shown to 
induce early autoimmune diseases and IBD in mice, 
indicating that this cytokine plays a major role in 
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preventing autoimmune responses (Kulkarni et al., 1993; 
Shull et al., 1992). Altogether, this regulatory cytokine has 
been shown to have a diverse effect on the immune system 
in terms of maintaining tolerance and would be an 
important candidate for further investigation, as its 
upregulation may be a distinctive feature of semi-mature 
DCs. Intriguingly, searching for other important 
candidates, upregulated in B. vulgatus mpk stimulated 
DCs, we discovered several other proteins, related to 
protection from oxidative stress. In this thesis, we chose to 
further investigate the involvement of these proteins in 
IBD.  
Oxidative stress is thought to be one of the leading 
causes of intestinal inflammation (Buffinton & Doe, 1995; 
D'Odorico et al., 2001; Keshavarzian, Morgan, Sedghi, 
Gordon, & Doria, 1990; Keshavarzian et al., 1992; 
Koutroubakis et al., 2004; Kruidenier, Kuiper, Lamers, & 
Verspaget, 2003; Kruidenier, Kuiper, Van Duijn, et al., 
2003; Lih-Brody et al., 1996). We were able to show that 
E. coli stimulated fully mature DCs harbor more ROS than 
B. vulgatus stimulated, semi-mature and unstimulated, 
immature DCs. As the adverse effects of excessive ROS 
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production is well documented, high amounts of ROS 
combined with impaired stress response mechanisms we 
observed (discussed in the following paragraph) can be 
detrimental for the organism. ROS overproduction can 
cause severe damage to vital molecules such as lipids, 
carbohydrates, proteins and DNA and thus influence main 
functions of the cell. DNA lesions, caused by the 
interaction with oxidative molecules, have been shown to 
be relevant to mutagenesis (Hussain et al., 2000) and 
eventually lead to intestinal tumorigenesis (D'Inca et al., 
2004; Dincer et al., 2007; Ferguson, 2010; Meira et al., 
2008). Lipid oxidation end-products, such as 4-
hydroxynonenal (HNE) and oxysterols have been shown 
to be crucial for developing chronic inflammation, as 
aldehydes and cholesterol are the main substrates for 
prostaglandins (PGs) and for leukotriene (LT) formation 
(Mascia et al., 2010; Nair et al., 2006; Rezaie, Parker, & 
Abdollahi, 2007). Based on this data, it is tempting to 
speculate that the observed redox imbalance is one of the 
driving factors for the phenotypical differences we 
observed between semi-mature and fully mature DCs. It 
has been demonstrated that ROS can directly stimulate 
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secretion of inflammatory cytokines via activation of 
NFκB and other inflammatory pathways (Asehnoune, 
Strassheim, Mitra, Kim, & Abraham, 2004; Cruz et al., 
2007). Direct and indirect activation of the inflammasome 
by ROS has also been reported (Dostert et al., 2008; 
Martinon, 2010). 
In addition, free radicals can cause disruption of the 
mucosal barrier, characterized by increased permeability 
and impaired wound healing (Banan et al., 2000; A. Wang 
et al., 2014). Disintegration of the colonic epithelium, 
caused by ROS, has already been shown in CD patients in 
quiescent stage (Rao, Baker, Baker, Gupta, & Holycross, 
1997). Furthermore, 40% of the first-degree relatives have 
increased intestinal permeability without any 
inflammation signs (Buhner et al., 2006; Fries et al., 2005). 
Once the mucosal barrier is damaged, pathogenic bacteria 
can infiltrate the sterile submucosa and initiate numerous 
destructive cascades of immune response (Banan et al., 
2000; Fasano & Shea-Donohue, 2005). Besides local 
tissue damage, impaired intestinal barrier function, 
referred to as “leaky gut syndrome”  has been linked to the 
development of extraintestinal diseases, including 
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multiple sclerosis, ankylosing spondylitis, asthma, type 1 
diabetes, autoimmune hepatitis (Fasano, 2012; Lin, Zhou, 
Zhang, & Wang, 2015). The etiology of the leaky gut is 
poorly understood, however it has been associated with 
loosening of intestinal epithelial tight junctions in a 
zonulin dependent manner. (Fasano et al., 2000; W. Wang, 
Uzzau, Goldblum, & Fasano, 2000). This may lead to 
increased paracellular passage of antigens, represented by 
food components (e.g. gluten in celiac disease) or bacterial 
epitopes. The abnormal antigen delivery to the well 
vascularized submucosa may trigger a strong immune 
reaction, which increases the chances for an autoimmune 
process. As ROS is a potential cause of mucosal barrier 
disruption and thereby the development of leaky gut 
syndrome, a detailed investigation of the molecular 
mechanisms behind oxidative stress may be crucial for 
understanding the origin of IBD and many other chronic 
diseases. 
Numerous studies report that ROS are inducers of 
inflammation rather than mere byproducts of it. Studies 
from 1980s show that oxidizing agents are able to induce 
severe colitis in mice with typical clinical and histological 
    
                           
Discussion 
 
107 
 
features of the disease (Bilotta & Waye, 1989; Meyer, 
Brand, DeLuca, & Spiro, 1981). This was observed after 
administration of H2O2, used at this time to treat fecal 
impaction. Another study showed that mice deficient in 
antioxidant genes (i.e. glutathione peroxidase gene), 
developed an intestinal inflammation consistent with the 
symptoms and pathology of IBD (Esworthy et al., 2001).  
Mice lacking the antioxidant enzyme showed increased 
ROS abundance which caused a crypt destructive colitis, 
similar to UC (Esworthy et al., 2001). Although these 
studies cannot be taken as a definitive basis to prove 
causality, they strongly indicate that redox imbalance has 
an etiological role in IBD.  
In the Stress response cluster (see Figure 10A) we 
discovered many antioxidant enzymes as well as a crucial 
regulatory protein of anti-oxidative cascades, called 
Prohibitin (Phb1). All of them were differentially 
regulated upon stimulation with commensal bacteria. 
Prohibitin was found to be upregulated in B. vulgatus mpk 
stimulated DCs compared to E. coli mpk2 stimulated DCs. 
Our Western blot supported this finding, showing slightly 
increased Phb1 amount in B. vulgatus mpk stimulated 
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DCs. Phb1 drew our attention, as it has previously been 
shown to protect against oxidative stress and to attenuate 
colitis in mice (Theiss et al., 2007; Theiss, Vijay-Kumar, 
et al., 2009). Additionally, Prohibitin abundance was 
shown to be decreased in patients with Crohn’s disease as 
well as in two distinct models of experimental colitis, 
showing that Phb1 is less expressed under inflammatory 
conditions. Moreover, in vitro experiments showed that in 
an oxidative environment, Prohibitin expression is reduced 
as well, but after removing the oxidative agents, it is 
restored to normal levels (Theiss et al., 2007). Our results 
extend the reports of previous findings which were 
performed on colonic epithelial cells in vitro and in vivo. 
In our study we analyzed Phb1 expression in distinct DC 
maturation states. Mature DCs, which were stimulated 
with the colitogenic E. coli mpk2, showed decreased levels 
of Phb1, similar to the colonic epithelial cells under 
inflammatory conditions. On the other hand, in our 
proteome and Western blot experiments, dendritic cells 
stimulated with the protective B. vulgatus mpk showed 
increased Prohibitin expression. This is an interesting 
observation as it has been previously shown that 
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restoration of Prohibitin levels via Phb1 overexpressing 
transgenic mice or using recombinant adenovirus vectors 
ameliorates colitis (Theiss, Jenkins, et al., 2009; Theiss et 
al., 2011). Considering ample research data mentioned 
above, we propose that Phb1 is a crucial protein for 
mediating the protective properties of B. vulgatus mpk in 
colitis. 
Mechanically, on a pathway level, Phb1 is primarily 
linked to the positive regulation of Keap1-Nrf2 pathway 
(see Figure 16), which is one of the most important 
pathways for fighting excessive oxidative stress (Bocci & 
Valacchi, 2015; Sykiotis & Bohmann, 2010; Theiss et al., 
2007). More details on the mechanism of action of 
Prohibitin was later provided by (Kathiria, Butcher, 
Hansen, & Theiss, 2013; Theiss, Jenkins, et al., 2009), 
showing that Phb1 is able to directly inhibit TNFα induced 
activation of NFκB and thus to impair the production of 
inflammatory cytokines. The latter strongly suggests that 
Phb1 is capable of modulating intestinal inflammation in 
Nrf2 independent manner as well. 
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Figure 16: Regulation of Keap1-Nrf2 
The image is adopted and modified from Sykiotis and Bohmann (2010). 
Keap1-Nrf2 pathway is major antioxidant pathway in the cell. Under 
normal condition the transcription factor Nrf2 is repressed by the Keap1 
protein and undergoes targeted degradation in the proteasome. Under 
oxidative stress (ROS), Keap1 releases Nrf2 to fulfill its role as a 
transcription factor. Prohibitin (PHB1) and P62 promote Nrf2 
accumulation in the nucleus as well and thus the transcription of 
Antioxidant Response Elements (ARE).   
Nrf2 is a transcription factor which is repressed under 
normal conditions by Keap1. Normally the protein 
complex has a short half-life in the cytoplasm (20min) and 
if not used, it is degraded in the proteasome. However, in 
the presence of oxidants, electrophiles or sulforaphanes, 
Nrf2 is released and accumulates in the nucleus, where it 
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is responsible for the transcription of Antioxidant 
Response Elements (AREs) (Bocci & Valacchi, 2015; 
Ishii, Itoh, & Yamamoto, 2002; Kensler, Wakabayashi, & 
Biswal, 2007). Interestingly, after assessing our previously 
established stress response cluster list (see Figure 10 
above), we found 4 major representatives of the 
Antioxidant Response Elements (i.e. superoxide 
dismutase (Sod1), glutathione s-transferase omega-1 
(Gsto1), thioredoxin (Txn) and glutamate-cysteine ligase 
(Gclm)). All of them were expressed more in B. vulgatus 
mpk stimulated DCs compared to unstimulated and E. coli 
stimulated DCs. Presumably, fighting oxidative stress via 
activation of Nrf2 is an important feature of semi-mature 
DCs and that may be a key factor in protection from colitis. 
Khor et al. (2006) showed that Nrf2-deficient mice are 
more susceptible to develop DSS-induced colitis than wild 
type. Furthermore, antioxidants e.g. Sod1, Trx have been 
shown in multiple studies to attenuate colitis in 
experimental mice models (Kruidenier, van Meeteren, et 
al., 2003; Oz, Chen, McClain, & de Villiers, 2005; Segui 
et al., 2005; Tamaki et al., 2006). Altogether, these 
findings indicate the importance of this major anti-
    
                           
Discussion 
 
112 
 
oxidative pathway in IBD, which is not surprising as 
oxidative stress plays a significant role in the pathogenesis 
of intestinal inflammation (Biasi, Leonarduzzi, Oteiza, & 
Poli, 2013; Grisham, 1994; Iborra et al., 2011; Kruidenier, 
Kuiper, Van Duijn, et al., 2003; Kruidenier & Verspaget, 
2002; Moret et al., 2014). 
Therapeutic applicability of antioxidants or 
regulatory proteins such as Prohibitin can be further 
studied in the future, as they may have the potential to 
ameliorate IBD. Considering the “leaky gut” hypothesis, 
the use of antioxidants or prohibitin may be beneficial not 
only for managing intestinal pathologies, but also in 
treating many other chronic inflammatory and 
autoimmune conditions as well. Additionally, as B. 
vulgatus mpk is able to protect from excessive ROS 
production via activation of antioxidant pathways, the 
therapeutic applicability of probiotics containing B. 
vulgatus mpk, can also be investigated in IBD or other 
ROS related diseases such as Celiac disease, Type 1 
Diabetes, Asthma, Multiple sclerosis, Ankylosing 
spondylitis.
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5 Conclusion  
In this study we aimed at gaining more insight into 
inflammatory bowel disease by investigating the 
immunological factors mediating it. We used a proteomics 
approach targeting dendritic cells, stimulated with the 
symbiotic B. vulgatus mpk or pathobiotic E. coli mpk2. 
Stimulation with symbiotic bacteria resulted in: 
(i) reduced activation and maturation of dendritic 
cells 
(ii) reduced inflammation and migration of 
dendritic cells 
(iii) decreased accumulation of ROS 
(iv) activation of countermeasures to oxidative 
stress  
The reduced ability of B. vulgatus mpk to activate and 
maturate DCs is indicated by inhibition of 
proinflammatory cytokine secretion i.e. TNFα, IL-6, IL-
12p40 and IL-1β and the difference in surface expression 
markers such as MHC class II and CD40. B. vulgatus mpk 
stimulated samples show downregulation in 
proinflammatory pathways and processes, exemplified by 
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a downregulation of proteins which are part of the TLR4-
signalling pathway, formation of the inflammasome and 
chemokine guided migration. In addition to decreased 
proinflammatory gene expression, increased expression of 
the anti-inflammatory protein TGFβ was detected as well, 
suggesting an involvement of semi-mature DCs in 
induction of peripheral tolerance. We were also able to 
show that DCs stimulated with the symbiotic B. vulgatus 
mpk harbor basal ROS amounts, whereas the pathobiotic 
E. coli mpk2 induces high levels of reactive oxygen 
species in DCs. Additionally, we detected an increase of 
the antioxidant capacity in semi-mature DCs, 
characterized by upregulation of important antioxidant 
enzymes i.e. SOD1, GSTO1, TXN, GCLM1 and 
regulatory proteins such as Prohibitin. These proteins all 
belong to the pivotal, cytoprotective Nrf2-Keap1 pathway, 
which is a major pathway in maintaining redox 
homeostasis. We believe that altered redox homeostasis, 
induced by continuous interaction with pathobionts, can be 
a crucial cofactor for developing intestinal inflammation 
and other autoimmune disorders. We postulate that 
symbiotic bacteria are able to trigger the activation of 
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cytoprotective, antioxidant pathways such as Nrf2-Keap1 
pathway, which may contribute to their protective effect in 
IBD. All aforementioned proteins are summarily 
visualized in this study and can serve as a proteomics map 
to guide researchers for a better understanding of DC 
maturation and inflammatory conditions. Our proteomics 
catalogue also includes potential drug targets (e.g. 
Prohibtin, SOD1), which may be used for developing 
successful therapeutic strategies for IBD. Considering the 
immune regulatory properties of B. vulgatus mpk, shown 
by previous studies and this proteome study, the use of B. 
vulgatus mpk in probiotic combinations for treating 
intestinal inflammation may prove beneficial. We hope 
that our results will open new venues in the knowledge of 
dendritic cell maturation and associated mechanisms of 
intestinal inflammation.  
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6 Zusammenfassung 
Ziel dieser Arbeit war es, einen Einblick in die Rolle 
symbiotischer oder pathobiotischer kommensaler 
Bakterien bei der Pathogenese chronisch entzündlicher 
Darmerkrankungen zu bekommen. Mithilfe von 
Proteomics wurde das Proteinexpressionsprofil 
dendritischer Zellen untersucht, die entweder mit dem 
symbiotischen Stamm B. vulgatus mpk oder 
pathobiotischen Stamm E. coli mpk2 stimuliert wurden. 
Die Stimulation mit symbiotischen Bakterien führte zu  
(i) einer verringerten Aktivierung und Maturation 
dendritischer Zellen,  
(ii) einer reduzierten Inflammation und Migration 
dendritischer Zellen  
(iii) einer verringerten Akkumulation reaktiver 
Sauerstoffspezies (ROS)  
(iv) einer Aktivierung von 
Gegenregulationsmechanismen gegen 
oxidativen Stress.  
Die Fähigkeit von B. vulgatus mpk, dendritische Zellen in 
semimature dendritische Zellen zu differenzieren und 
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somit die komplette Maturation zu verhindern, lässt sich 
an z. B. der Hemmung der proinflammatorischen 
Zytokinsekretion (TNFα, IL-6, IL-12p40 und IL-1β), 
sowie unterschiedlichen Expressionsmustern von 
aktivierungs- und maturationsassoziierten 
Oberflächenmarkern wie z.B. MHC Klasse II und CD40 
erkennen. B. vulgatus mpk stimulierte dendritische Zellen 
zeigten zudem eine Herunterregulation 
proinflammatorischer Signalwege und Prozesse, indem z. 
B. Proteine, die zum TLR4 Signalweg, zur Inflammasom-
Bildung, sowie zur Migration bei Entzündungsprozessen 
gehören, in geringerem Maß, als bei maturen dendritischen 
Zellen, exprimiert wurden. Ergänzend konnten wir zeigen, 
dass antiinflammatorische Proteine, wie z.B. TGFβ, in 
Folge einer B. vulgatus mpk Stimulation hochreguliert 
wurden, was auf eine Beteiligung semimaturer 
dendritischer Zellen bei der Entstehung von peripherer 
Toleranz hindeuten könnte. Darüber hinaus konnten wir 
zeigen, dass dendritische Zellen mit einer geringeren 
Menge ROS auf eine Stimulation mit B. vulgatus mpk 
reagierten als auf eine Stimulation mit E. coli mpk2. 
Zusätzlich konnten wir eine Steigerung des antioxidativen 
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Potentials semimaturer dendritischer Zellen nachweisen, 
das durch die Hochregulation wichtiger antioxidativer 
Enzyme wie SOD1, GSTO1, TXN, GCLM1, sowie 
regulatorischer Proteine wie beispielsweise Prohibitin 
gekennzeichnet war. Diese Proteine gehören zum Nrf2-
Keap1 Signalweg, der eine große Bedeutung bei 
antioxidativen und zytoprotektiven Prozessen hat und 
damit entscheidend für die Aufrechterhaltung der 
Redoxhomöostase ist. Wir denken, dass eine veränderte 
Redoxhomöostase, die durch eine kontinuierliche 
Exposition gegenüber Pathobionten hervorgerufen wird, 
ein entscheidender Kofaktor für die Entstehung chronisch 
entzündlicher Darmerkrankungen und anderer 
Autoimmunerkrankungen ist. Wir postulieren, dass 
symbiotische Bakterien in der Lage sind zytoprotektiv und 
antioxidativ zu wirken, indem sie Signalwege wie Nrf2-
Keap1 aktivieren und somit einen Schutz vor chronisch 
entzündlichen Darmerkrankungen vermitteln können. Die 
oben genannten Proteine sind ein Teil der graphisch 
dargestellten, in dieser Studie identifizierten, differentiell 
regulierten Proteine. Diese “Proteomics map” kann 
anderen Wissenschaftlern, beispielsweise im Rahmen von 
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Arzneimittelentwicklung (z.B. Prohibtin, SOD1), als 
Grundlage dienen. Die immunregulatorischen 
Eigenschaften von B. vulgatus mpk, die in früheren 
Studien gezeigt wurden und die wir mittels Proteomics 
bestätigen konnten, lassen die Schlussfolgerung zu, dass 
B. vulgatus mpk als Probiotikum bei der Behandlung von 
chronisch entzündlichen Darmerkrankungen in Zukunft 
Anwendung finden könnte. Unsere Ergebnisse tragen zum 
Verständnis der Maturation und Semimaturation DZ und 
deren Rolle bei chronisch entzündlichen 
Darmerkrankungen bei. 
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7 Abbreviations 
·O2
- Superoxide anion 
·OH Hydroxyl radical 
1O2 Singlet oxygen 
Ab Antibody 
Actn4 Actinin, alpha 4 
Aif Apoptosis-inducing factor 
AKT1 RAC-alpha serine/threonine-protein 
kinase 
ANOVA Analysis of variance 
APC Allophycocyanin 
APCs Antigen presenting cells 
APS Ammonium Persulfate 
AREs Antioxidant response elements 
Arg1 Arginase 1 
B. vulgatus  Bacteroides vulgatus 
BHI Brain heart infusion 
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BHI Brain heart infusion 
BMDC Bone marrow derived dendritic cell 
BSA Bradford standard assay  
BV B. vulgatus 
C/EBPβ CCAAT-enhancer-binding protein β 
CaCl2 Calcium chloride 
Casp1 Caspase 1 
CAT Catalase 
CCL5 Chemokine (C-C motif) ligand 5 
CCR Chemokine receptor 
CD Crohn’s disease 
CD Cluster of Differentiation 
CO2 Carbon dioxide 
Coro1 Coronin-1a 
CpG Cytosin-Phosphat-Guanin 
Cu Copper 
DCF Dichlorofluorescein 
    
                 
Abbreviations 
  
122 
 
DCFH-DA 2,7-dichlorodihydrofluorescein 
diacetate 
DCs Dendritic cells 
DMSO Dimethyl sulfoxide  
DNA Deoxyribonucleic acid  
E. coli Escherichia coli 
e.g.  exempli gratia (for exmple) 
EC E. coli 
ELISA Enzyme-linked immunosorbent 
assay 
ETC Electron transport chain 
FACS Fluorescence activated cell sorting 
FCS Fetal calf serum 
FITC Fluorescein isothiocyanate  
Fn1 Fibronectin 1 
Foxp3 Forkhead box protein 3 
GALT Gut associated lymphatic tissue 
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GCL Glutamate-cysteine ligase 
GCLM Glutamate-cysteine ligase, modifier 
subunit 
GF Germ free 
Glns Glutamine synthetase 
GM-CSF Granulocyte macrophage colony-
stimulating factor 
GPx Glutathione peroxidase 
GRx Glutathione reductase 
GSH Glutathione 
GSSG Oxidized glutathione 
GSTO1 Glutathione s-transferase omega-1 
h Hour 
H2O2 Hydrogen peroxide 
H2O2 Hydrogen peroxide 
HLA Human Leukocyte Antigen 
HNE 4-hydroxynonenal 
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HRP Horse radish peroxidase 
Hsp Heat-shock protein 
i.e. id est (that is) 
IBD Inflammatory bowel disease 
Ifi75 Interferon-induced protein 75 
IFN Interferon 
Ig Immunoglobulin 
IL Interleukin  
Keap1 Kelch-like ECH-associated protein 
1 
LB Lysogeny broth 
LBP LPS-binding protein 
LP Lamina propria 
LPS Lipopolysaccharide  
LT Leukotriene 
mAB Monoclonal antibody 
MACS Magnetic activated cell sorting 
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Mcl1 Induced myeloid leukemia cell 
differentiation protein 
MgCl2 Magnesium chloride 
MHC Major histocompatibility complex 
min Minute 
MLN Mesenteric lymph nodes 
Mn Manganese 
Mo Mock 
MOI Multiplicity of infection 
MPs Mononuclear phagocytes 
mRNA Messenger ribonucleic acid 
MyD88 Myeloid differentiation primary 
response protein 88 
Myh9 Myosin, heavy chain 9 
NaOH Sodium hydroxide 
NDRG1 N-Myc Downstream Regulated 1 
NF-κB Nuclear factor 'kappa-light-chain-
enhancer' of activated B-cells 
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NLRs NOD-like receptors 
Nrf2 Nuclear factor erythroid 2-related 
factor 2 
OD Optical density 
p62/SQSTM1 Ubiquitin binding protein 
62/Sequestosome-1 
PAGE Polyacrylamide gel electrophoresis 
PAMPs Pathogen-associated molecular 
patterns 
PBS Phosphate buffered saline 
PBS Phosphate Buffered Saline 
PCR Polymerase chain reaction 
PE Phycoerythrin 
PFA Paraformaldehyde  
PG Prostaglandin 
PHB Prohibitin 
PPRs Pattern-recognition receptors 
PSC Primary sclerosing cholangitis 
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QBiC Quantitative Biology Center 
RO· Alkoxyl radical 
ROO· Peroxyl radical 
ROS Reactive oxygen species 
RS· Thiol radical 
Rtn4 Reticulon-4 
SD Standard deviation 
SDS Sodium dodecyl sulfate 
Ship1 SH2 domain-containing inositol 5'-
phosphatase 1 
SOD Superoxide dismutase 
SPF Specific pathogen free 
STAT Signal transducer and activator of 
transcription 
Stat Signal Transducer and Activator of 
Transcription 
Strep. Streptavidin 
TEMED Tetramethylethylenediamine 
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TGFβ Transforming growth factor beta 
Th T-helper cell 
TLRs Toll-like receptors 
TNFα Tumor necrosis factor alpha 
Treg regulatory T-cell 
Tris Trisaminomethane 
TXN Thioredoxin 
UC Ulcerative colitis 
UV Ultra violet 
vs Versus  
Zn Zinc 
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